header logo image


Page 5«..4567..10..»

Archive for the ‘Longevity Genetics’ Category

These are the signs and symptoms of dementia – and the stages explained – Yorkshire Post

Thursday, December 17th, 2020

Read This

Tuesday, 15th December 2020, 8:31 am

According to the NHS, there are around 850,000 people in the UK living with dementia.

Following the death of actress Dame Barbara Windsor on 10 December, there has been much discussion around how dementia affects people and families and what can be done to prevent it from becoming aggressive.

The condition is linked with old age and lifestyle habits, but there is a range of things you can do to decrease your likelihood of developing dementia or to reduce the severity of the illness.

The term dementia is related to the symptoms and changes caused by various diseases in the body.

These symptoms include struggling with problem solving, memory loss, confusion and behaviour changes.

Dementia is not a disease nor is it a natural part of ageing - instead it is the name given to the impact of other diseases which have a negative effect on daily life.

The most common disease that causes dementia is Alzheimers.

Vascular dementia on the other hand is caused by diseased blood cells. Blood vessels can become blocked and deprive the brain of oxygen.

Other illnesses such as alcohol related brain disorder and strokes may also alter how the mind works and cause dementia.

The impact of dementia on each person can vary depending on what part of the brain is affected and what disease is causing it.

Some strains of dementia have been linked to genetics in a small number of cases.These people may inherit dementia through a specific gene and are likely to be diagnosed before the age of 65.

The majority of people will carry a number of genes which can increase and decrease the risk of dementia.

These can be exacerbated by their lifestyle habits.

What are the early signs and symptoms?

Dementia is a degenerative disease, meaning it will get progressively worse over time.

There are different signs and symptoms experienced at the early and later stages of dementia.

According to Alzheimers society, common early symptoms include problems with:

- recalling recent events and memory loss

- Difficulty concentrating, planning or organising this could include being unable to follow a sequence of tasks, such as cooking a meal

- misusing or struggling with common language using the wrong words to describe or label something or struggling to piece together a sentence.

- visuospatial skills for example, problems judging distances (such as on stairs) and seeing objects in three dimensions,

- orientation getting lost in common places or being unable to recall the day or date

A recent study published by Dr Davide Bruno at the School of Psychology at Liverpool John Moores University (LJMU) also suggested forgetting the start of a story could be a tell-tale sign of early onset of dementia.

What long-term effects can dementia have?

Alzheimers is thought to have the slowest progression rate, while dementia caused by strokes or vascular dementia may have a significant impact on memory and cognitive ability in a shorter period.

People experience different symptoms at different stages, however, some of the more progressive challenges are:

- lack of mobility - this can be caused by medication, dementia diseases or a combination of dementia and the other factors which resulted in the diagnosis - such as having a stroke or high blood pressure.

- an increasingly poor memory - a dementia patient may begin to lose their memory of significant people or times in their life as the disease progresses.

- loss of communication - the inability to verbalise what they want to say, struggling to understand what is being asked of them or limited speech.

- weight loss and eating - in the later stages of dementia, patients may lose a considerable amount of weight due to a lack of appetite or inability to chew and swallow. Weight loss can lead to a poor immune system and inability to fight infections and struggling to physically eat could be a choking hazard. You should contact your GP if you are concerned about someone with this symptom of dementia.

What lifestyle habits may increase your likelihood of having dementia?

There are thought to be a number of factors which result in dementia and many are linked to health and lifestyle habits which form and continue throughout your life.

There are also factors which are unavoidable and dementia cannot be completely prevented.

Habits which could reduce your risk are:

- Eating a healthy diet - a balanced diet which includes protein, fats and carbs and is high in nutrient rich food such as fruits and vegetables can help prevent dementia and cancer, type 2 diabetes, obesity, stroke and heart disease.

- Exercising regularly - take part in two and a half hours of aerobic exercise - such as walking or cycling - per week, as well as some strengthening exercises

- Do not smoke - smoking inhibits the ability for blood vessels to carry oxygenated blood around the body and can lead to strokes, cancer and high blood pressure too.

- Avoid drinking excessive amounts of alcohol - at most, you should aim to drink no more than 14 units each week, spread across at least three days. If you regularly drink much more than this, youre at risk of alcohol-related brain damage.

Challenge your mind - keeping your mind active is one of the most important ways to reduce the onset and severity of dementia. Think use it or lose it - try studying a new language, completing crosswords, playing cards or board games and reading.

Factors which you cannot control are:

- Age - people over the age of 65 are most likely to suffer from dementia related diseases and it affects one in six people over 80.

- Sex - women are more likely to suffer from dementia than men, even after longevity is taken into account. It is not known why this is.

- Ethnicity - South Asian people (from countries such as India and Pakistan) and people of African or African-Caribbean origin seem to develop dementia more often. They are known to be more prone to diabetes and stroke and this is thought to be more closely related to lifestyle and diet factors than genetics.

Currently, there is no cure for dementia, however there are therapies and drugs which can alleviate some of the related symptoms..

While drugs can curtail some of the effects, person-centred care such as taking part in hobbies and interests which the dementia patient has enjoyed throughout their past and recent years can support memory.

Psychological therapies can also support people who are struggling to cope with the confusion around dementia, and the changes they experience with regards to their mood and behaviour.

Continuing to eat healthily, exercise, read and avoid smoking and drinking will also support in slowing the progression to varying degrees.

For anyone experiencing dementia, or if you care for someone with dementia, support can be found via the following charities:

Age UK's Advice Line - 0800 055 6112 - 8am to 7pm everyday

Dementia UK - 0800 888 6678 - 9am to 9pm weekdays, 9am - 5pm weekends

Here is the original post:
These are the signs and symptoms of dementia - and the stages explained - Yorkshire Post

Read More...

Manahawkin Woman ‘Scales’ 100 Years With Service, Strength and Determination – The SandPaper

Thursday, December 17th, 2020

Catherine Kate Scales (center) has lived in Manahawkin since 1959 and was partly responsible for the development of Stafford Townships first master plan. (Supplied photo)

In 1920, women in the U.S. were given the right to vote, Warren Harding was elected the 29th president, movies were silent and televisions didnt yet exist, the American Civil Liberties Union was founded, Agatha Christies first novel was published, and American football became a professional sport.

Later that year, on Oct. 27, Catherine Kate Scales was born in Jersey City, but as she grew a slight problem arose she was allergic to regular milk.

I didnt like regular milk anyway, she recently said, bursting with laughter, from her home on North Lakeshore Drive in Manahawkin, several weeks after celebrating her 100th birthday. But I was raised on goats milk, and I really believe that has something to do with why Im still around.

Certainly, thats one of several viable possibilities for why Scales has lived through 17 presidencies, 10 decades worth of revolutionary changes throughout the nation, and the immense development of Stafford Township. But lets consider the others for a moment.

I have a vodka and tonic every night before dinner, just one while dinner is cooking, she said, sounding quite proud of that fact. Ive had a lot of good luck, too. Under a lot of different circumstances, things have worked out for me.

So well, shes rarely entered a hospital.

I went to the hospital for childbirth and to have a bunion taken off my foot, she said. I dont go to hospitals except to visit people. I have my tonsils, appendix and all that good stuff. Ive been healthy. I really think it was the goats milk.

Stafford Township Mayor Greg Myhre presents a proclamation and key to the city to Kate Scales on her 100th birthday, as family and friends celebrated in a drive-by way. (Supplied photo)

Whatever the reasons for her longevity, whats more fascinating about the woman who once was asked by both the Stafford Republican and Democratic clubs to run for mayor she dismissed that request by telling those who asked she didnt lie well enough to be a good politician is not that shes lived 100 years, but how shes lived through those years.

One of two girls to a mother widowed by the time she was 2 years old, Scales grew up in Jersey City and, not long after the bombing of Pearl Harbor, she made a decision that shocked her mom.

I went into the Navy in 1942, because thats where all the boys were, she said with a chuckle. But we had no boys in the family, and this was my country and we all had stars in our eyes in those days. So, I just joined. I came home and told my mother and she said, You cant do that. I said, Mama, I already did it. I knew youd say no, so I didnt ask you. I was 22 when I went in.

While serving during World War II, she became a celestial navigation instructor for naval pilots and fulfilled the role for two years, 10 months and 11 days.

Somebody said to me at the beginning of my service, Dont volunteer for anything because theyll give you the opposite, so I didnt know anything, she said, a bit of a coy emphasis to the explanation. They needed mechanics someplace out in Oklahoma, so I looked at this list of tools and I said, I think that might be a hammer. I knew what it was, but I wasnt telling them that. I didnt want to be some grease monkey for the Navy. I may as well have stayed home and worked in an office in New York.

After serving with the Navy, Scales did in fact go to work in an office in New York City as a secretary to a very fine gentleman named Howard Book with Reed Roller Bit Co. but not before she graduated with a degree in English literature from Fordham University.

I went to college under the G.I. Bill, she said. I was very grateful for that, because I couldnt have gone to school without it. I wouldnt have been able to afford it. But I had big plans. I was going to work in New York until 40, then go to Cape Cod, teach in the winter and have a boarding house in the summer. That didnt happen.

Instead, she met the man who became her husband, Michael Scales, on a blind date set up by her sisters sister-in-law.

She said, I have this nice gentleman for you, and I said, If hes so nice, why didnt you take him? Whats wrong with him? She said he was too young for her, but he wasnt much younger, Kate recalled. I agreed to meet for a drink in Rockefeller Plaza and I told her not to leave me with him. She introduced us and left. I couldve killed her. She left me with this strange fellow, who happened to be British.

That blind date occurred in 1954 and the couple married in 1956. Three years later, they moved to Manahawkin after the company for which Michael worked, Ciba-Geigy, moved from Pennsylvania to Toms River. Scales has lived on the same street next to Manahawkin Lake since, and even had some influence on the booming development of Stafford Township through the 1960s and 70s.

Kate Scales spent nearly three years as a celestial navigation instructor for the U.S. Navy during World War II. (Supplied photo)

While her husband traveled a lot for his job, Kate got involved within the township, eventually making her way onto the planning board. At the time, the town didnt have a master plan. She ultimately chaired the planning board and was part of the committee that developed the first master plan.

Some gentlemen said to me, Mrs. Scales, they just made you the head of the planning board. How would you like to be addressed? Well, everybody there was friendly, and wed always have coffee and cake during our meetings. Everything was real matey, so I said, Just call me Madam. So, thats what they called me. All of a sudden, I was Madam this and Madam that. It was fun, she said.

But it was an exciting time for the town. At the time, the biggest store was Grants, downtown where the motor vehicle office is now. The town was just coming to life at that point. We did our best with the master plan, and I saw the town grow. It was a really nice time.

Scales also spent time as the night court clerk only temporarily, for about a year, because I couldnt stand doing that for too long, she said and was active with the American Legion, Stafford Historic Society and the historic preservation commission. For a few years, she also served as president of the Republican Club.

At 22, Kate Scales joined the U.S. Navy and didnt tell her mother she had done it until after she signed the paperwork to enlist. (Supplied photo)

All the while, she operated a printing and secretarial service from home while her children grew up and served as a job developer for the local Comprehensive Employment and Training Act (CETA) program, through which she helped teens get their high school diplomas while working and completing life and skills training during the Reagan administration.

Years later, following her husbands passing, Kate bought and operated an inn on Cape Cod, in West Harwich, for 13 years, before selling it so she could return to Manahawkin full-time to be closer to her grandchildren.

Ive had an interesting life, said Kate, who credits her grandfathers Scottish genetics Thomas Murray was the only postman in New York to complete his mail route during the blizzard of 1888, featured in The New York Times that year for at least some of her strength and longevity. I was always involved with stuff. And I am strong, not stubborn. If I say, I wont, I wont and if I say, I will, I will. But Im still here. I guess thats something special.

On her 100th birthday, family and friends delivered a drive-by celebration orchestrated by her granddaughter Erika in which relatives from as far away as Texas made the trip just to camp out in the backyard, since there wasnt enough space in the house to accommodate many visitors, especially during the coronavirus pandemic. Mayor Greg Myhre also made a special visit to present a town proclamation recognizing Kates milestone and give her a key to the city.

I didnt see a reason he should have come by, but he did and gave me this key to the city, she said. It was nice of him to do that. I never saw the keys to the city, so it was something to get one. I havent tried to see if it works yet.

biggy@thesandpaper.net

See the rest here:
Manahawkin Woman 'Scales' 100 Years With Service, Strength and Determination - The SandPaper

Read More...

15 Things To Stop Doing If You Want To Live To 100 – Longevity LIVE – Longevity LIVE

Friday, December 4th, 2020

For those who have a family history of chronic diseases, this is great news because it means that you can take control of your future by taking control of your health. Furthermore, you can focus your attention on lifestyle factors that you can control as opposed to the genetics that you cant control.

Seriously, stop it.

The fact is that your favorite snacks, fast food meal, and other processed foods are rich in sugar, salt, and trans fats all of which greatly increase your risk for chronic diseases that include cancer, heart disease, hypertension, and diabetes.

You are what you eat and if you want to be the epitome of longevity, then you need to eat foods that improve your lifespan, not shorten it. Adopting a plant-based diet is a great way to ensure that your body gets all the nutrients it needs to keep itself healthy in the coming years. Having said that, eating healthy doesnt mean that you need to say goodbye to all of your favorite treats. They can still be enjoyed, just in moderation.

Continue reading here:
15 Things To Stop Doing If You Want To Live To 100 - Longevity LIVE - Longevity LIVE

Read More...

Ticking the boxes in a rain-fed dairy system – Dairy News Australia

Friday, December 4th, 2020

Significant bonuses from Fleckvieh calves and cull cows have been important cash flow tools in a rain-fed Victorian dairy herd this year.

This has come on top of the Fleckvieh attributes of longevity, fertility, robustness and temperament for Richard Humphris of Beech Forest.

Dr Humphris left consulting work as a veterinarian 20 years ago to go full-time dairying.

He milks 200 cows off 110ha set in a 2000mm rainfall zone comprising clay loam soils.

Richard has 69ha of lower rainfall country for growing out the rising one-year-old and two-year-old heifers.

Originally we had a fair proportion of stud Holstein-Friesians in the herd but when we moved (from South Australia) to this high rainfall climate, it was a fair challenge for standard Jersey and Friesian cows, Dr Humphris said.

We ran into problems with fertility and mastitis so we moved to a Jersey/Friesian cross using New Zealand sires.

With the low milk prices, I thought I needed to do something different and saw an advertisement for dual-purpose Fleckviehs about eight years ago.

It was ideal a dual-purpose cow producing milk with the value-added beef component.

Dr Humphris initially used Fleckvieh semen over selected cows and has graded up to the point where matings are 100 per cent Fleckvieh.

Most of the milking herd is now three-quarter-bred Fleckvieh.

Dr Humphris was visited on-farm in 2015 by Dr Thomas Grup of Bayern-Genetik, Germany, and South African researcher Dr Carel Muller.

Dr Muller encouraged him to do simple comparative trials of the Fleckvieh crosses against other crossbreeds through herd testing on longevity and lifetime production.

We get much greater longevity from the Fleckviehs due to better fertility, less mastitis and a better recovery if mastitis does occur, Dr Humphris said.

The Saputo suppliers have transitioned to once-a-day milking to reduce stress on the family and herd, and leave extra time for essential farm maintenance and pasture production.

The move also meant they could use the existing 20-a-side swing-over dairy, avoiding extra capital costs.

In the first year of once-a-day milking, the herd produced 75,000kg of milk solids and had jumped to 99,000kg by the third season.

The herd averages 3932 litres, 4.9 per cent butterfat, 3.8 per cent protein and 348kg of milk solids across 287 days.

Last herd test, the highest daily lactation was Flekmaid at (once-a-day milking, second lactation) 31.8 litres, 4.5 per cent butterfat, 3.2 per cent protein and 2.45kg of milk solids.

Rurex daughter Joygirl showed what Fleckvieh crossbreds are capable of under Australian conditions by producing 6209litres, five per cent butterfat, 3.8 per cent protein, and 569kg of milk solids across the 305 day lactation (once a day).

Components over the spring months in the herd are four per cent protein and 4.7 per cent butterfat, increasing to 4.2 per cent protein and five per cent butterfat over the summer.

The most important thing is their temperament, they are beautiful cattle to work with and they have the other option of beef income, Dr Humphris said.

Due to the once-a-day milking and the environment, we find we do need excellent udders with a particular emphasis on udder depth and suspensory ligament.

If a Fleckvieh has to leave the herd it will mainly be due to a low-slung udder.

We are getting some really good uddered cows coming through now and that has helped our udder health.

If they do get mastitis, I have observed Fleckviehs have a better ability to recover they are sturdy, robust cows in this harsh Victorian climate where it can snow in the winter.

Where another cow may produce more on an individual daily basis, these cows have the ability to go on for a lot longer than our traditional Australian genetics in terms of fertility, lack of mastitis and survivability.

We have very few problems with lameness compared with our earlier years with other breeds but once a day milking does contribute to this reduced lameness.

Dr Humphris said the Fleckvieh added frame to the smaller crossbred females.

Fleckvieh fertility and once-a-day milking results in high conception rates with 80 per cent on the first service in the August-calving herd.

The couple joins 100 per cent of the herd to Fleckvieh sires, and they have daughters of Round Up, Rijeka, Waldoer, Reumut, Mahango, Waldbrand and Walfried.

We mop up with Fleckvieh beef bulls the calves have been one of the most exciting complements to the whole exercise, Dr Humphris said.

This year I did not sell one calf for slaughter at five days of age they all went for pasture finishing to adult animals in the local area.

I either sold them at one week of age or at eight weeks of age as a reared calf.

This gives a significant cash flow at the beginning of lactation through the sale of those calves for continuing beef production.

This results in the equivalent of 50kg of milk solids start on any other cow in terms of profitability.

Dr Humphris said the value of cull cows was a bonus on top.

I recently sold Jersey/Friesian cross cows for $850 compared to $1200 for the Fleckvieh crosses, he said.

During his career as a vet, Dr Humphris has experienced a range of calving difficulties in cattle.

At the beginning I was rather cautious about what I would have to face up to with the Fleckviehs calving, he said.

But they dont require assistance unless there is a malpresentation.

We dont select sires on calving ease but rather for production, udders and milk quality.

Our heifers are calved at two years of age we are not convinced this is the best but it suits our system.

The milkers are rotationally grazed across perennial rye-grass pastures and fed a mixed grain ration of 2.5kg in the bail.

Dr Humphris and his wife Christine have travelled to Bavaria, in Germany, to experience the Fleckvieh breed in its native environment and inspect sires.

We aim to select the highest TMI bulls with a big focus on udder, shape and function, he said.

It was enlightening going over there, talking to the breeders and seeing 100 per cent Fleckvieh herds.

Offering dual-purpose flexibility, they are a breed well worthwhile considering as we face these different economic and climatic challenges.

We love our Fleckviehs. They have strength, vitality and production of milk and meat, and live for the moment.

The Fleckviehs have a wonderful temperament they live life to the full full of grass, full of milk and full of meat. They cycle full-on and conceive full-on.

For more information on Bayern Genetik, phone George Cassar on 0265507661.

Follow this link:
Ticking the boxes in a rain-fed dairy system - Dairy News Australia

Read More...

Barack Obama On Who Is The GOAT Between LeBron James And Michael Jordan: ‘LeBron James Is Not Quite There. We Don’t Know How Many More Rings He Might…

Tuesday, December 1st, 2020

Barack Obama has given his two pennies on the never-ending GOAT debate. The former president is an avid basketball fan, especially with his links with the city of Chicago and the Chicago Bulls. His opinion on NBA-related topics always matters and hes not done giving his takes about the hottest topics in the league right now.

More recently, he shared his opinion on the GOAT debate between LeBron James and Michael Jordan, explaining that James cant be called the GOAT since hes still playing and his rsum isnt finished. Bron can increase his legacy in the league and have a better case to be considered the greatest player of all time, surpassing MJ (47:05 mark).

LeBron is making strides in the GOAT debate. [But hes not quite there yet] Not quite because look, his career is not over yet. And we dont know how many more rings he might win.

Obama said that MJ is the greatest to ever do it for him, but that didnt prevent him from giving some flowers to Bron, who is showing that hes still an incredible player and his longevity is something unmatched in the league.

Heres what I will say about LeBron, who is indisputably, one of the top two already. His longevity. The fact that I joked about him because I was with him on The Shop right before the election.

You know, he doesnt look like hes lost a step. I know that he is benefiting from the kind of training and nutrition and treatments, and all that folks in Michaels generation just did not benefit from.

The 44th POTUS noted that James is a gifted player, hes built different and added to all the treatments he has on his body, his genetics have allowed him to become the player he is right now.

But part of it is just hes a freak. And right now it looks like he could keep on doing what hes doing right now for another five years, right? If at 40, hes still an All-Star and competing in this way, you know that you have to factor that in.

Bron is not done and he just won his 4th NBA championship in the Orlando bubble in October. The King is ready to go for the back-to-back with the Lakers and get closer to that GOAT title that, according to Obama, still belongs to MJ.

Comparing their regular season and playoffs accolades, Jordan is the clear GOAT but Bron is still there, trying to catch up with His Airness. Jordan has expressed that Bron could surpass him in a couple of years from now, which is something similar to what Obama said during his interview.

However, not everybody is convinced that is the truth. Hakeem Olajuwon recently claimed that Jordan is a better player than LeBron. Jordan leads LeBron in titles, MVPs, and Defensive Player of The Year awards, so the gap is still there.

Read more:
Barack Obama On Who Is The GOAT Between LeBron James And Michael Jordan: 'LeBron James Is Not Quite There. We Don't Know How Many More Rings He Might...

Read More...

20 Dog Breeds That Live the Longest – Reader’s Digest

Tuesday, December 1st, 2020

You dont want to even think about the day your cherished pooch is no longer by your side and crosses over the rainbow bridge. Its better to focus on the here and now and give your dog a healthy and happy life. But if youre wondering where your own pup stands or youre thinking about getting a specific type of dog, its good information to have. The bottom line: Size might matter when it comes to the longest dog life spans. There is a trend across mammals in general that smaller mammals live longer lives, says Catherine Lenox, DVM, a veterinarian for Royal Canin. There isnt a clear reason for thisit might have something to do with the animals metabolismbut it does seem to be true for dogs as well. Yet, other factors not relevant to size, such as poor genetics, unforeseen accidents, not getting enough exercise, and sudden illness, impact how long a dog lives, too.

According to Dr. Lenox, the following 20 dog breeds will live up to 15 years or even longer. While this is by no means an all-inclusive list and theres no guarantee that every dog noted here will live for this long, there are things you can do to help your dog live the longest, healthiest life possible. Be proactive about preventive care, manage medical conditions with your veterinarian as needed, keep your dog in normal body condition (not too heavy and not too thin), and feed a high-quality complete and balanced diet without too many treats, advises Dr. Lenox. Now that we have that squared away, lets see the cute pups!

Excerpt from:
20 Dog Breeds That Live the Longest - Reader's Digest

Read More...

Mutations of the coronavirus do not appear to make the virus more infectious, study says | TheHill – The Hill

Monday, November 30th, 2020

None of the mutations observed in the coronavirus that causes COVID-19 appear to increase the viruss transmissibility, a new study says.

The study led by researchers from University College London published Wednesday in Nature Communications analyzed a global dataset of virus genomes from more than 46,000 people with COVID-19 from 99 countries.

Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.

Researchers so far have identified more than 12,700 mutations in the SARS-CoV-2 virus.

Coronaviruses like SARS-CoV-2 mutate all the time and most are neutral. But some can be advantageous or detrimental to the virus, potentially with troublesome consequences, such as making the virus more contagious and a vaccine less effective.

But so far, researchers say they have yet to find any evidence common mutations are increasing the viruss transmissibility.

We realised early on in the pandemic that we needed new approaches to analyze enormous amounts of data in close to real time to flag new mutations in the virus that could affect its transmission or symptom severity, Lucy van Dorp, a professor at University College Londons Genetics Institute and a lead researcher of the study, said in a statement.

Fortunately, we found that none of these mutations are making COVID-19 spread more rapidly, but we need to remain vigilant and continue monitoring new mutations, particularly as vaccines get rolled out, she said.

Researchers found most of the viruss mutations occurred as a result of the human immune system response, rather than the result of the virus adapting to its human host.

Over the course of the pandemic, one mutation in the virus spike protein called D614Gwas reported as being a mutation that could make the virus more contagious than earlier strains that emerged out of Wuhan, China.

The study published Wednesday found the mutation is in fact not associated with a greater increase in transmission.

Francois Balloux, a UCL professor who worked on the research, said the virus posed no threat to COVID-19 vaccine efficacy at this time but warned the introduction of vaccines could exert new selective pressures on the virus to mutate to escape recognition by the humane immune system.

The news on the vaccine front looks great. The virus may well acquire vaccine-escape mutations in the future, but were confident well be able to flag them up promptly, which would allow updating the vaccines in time if required, Balloux said.

WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW

ONE THIRD OF PARENTS SAY THANKSGIVING WITH FAMILY IS WORTH THE RISK OF COVID-19

FAUCI CONFIRMS COVID-19 VACCINE COULD BE READY BY LATE DECEMBER, EARLY 2021

HOW TO COMPARE THE COVID-19 VACCINES FROM ASTRAZENECA, MODERNA AND PFIZER

SOUTH DAKOTA GOVERNOR REFUSES TO MANDATE MASKS DESPITE RECORD-BREAKING CORONAVIRUS SPIKE

PROJECTED US CORONAVIRUS DEATHS MORE THAN 400,000 BY MARCH

Read the original:
Mutations of the coronavirus do not appear to make the virus more infectious, study says | TheHill - The Hill

Read More...

Spaceflight does some weird things to astronauts bodies – MIT Technology Review

Monday, November 30th, 2020

The Twins Study gave us a first sketch of the human bodys molecular responses to spaceflight, but these outlines needed to be filled in, says Christopher Mason, an associate professor of physiology and biophysics at Weill Cornell Medicine. The changes we saw needed more context and replication. We needed additional studies to map out the frequency of the changes we observed in other astronauts, and other organisms, that go into space, and also to see if the degree of change was similar for shorter missions.

That brings us to a new package of research that builds on the Twins Study, reanalyzing some of the original data with new techniques and providing comparisons with other astronauts. In a set of 19 studies published today in a slew of different journals (along with 10 preprints still under peer review), researchers like Mason (a senior author on 14 of the papers) studied the physiological, biochemical, and genetic changes that occurred in 56 astronauts (including Kelly) who have spent time in spacethe largest study of its kind ever conducted.

The new papers, which incorporate results from cell-profiling and gene-sequencing techniques that have become easier to run only recently, reveal that there are some features of spaceflight that consistently appear in humans, mice, and other animals when they go to space, says Mason. There appears to be a core mammalian set of adaptations and responses to the rigors of spaceflight.

The researchers highlightsix biological changesthat occur in all astronauts during spaceflight: oxidative stress (an excessive accumulation of free radicals in the bodys cells), DNA damage, dysfunction of the mitochondria, changes in gene regulation, alterations in the length of telomeres (the ends of chromosomes, which shorten with age), and changes in the gut microbiome.

Of these six changes, the biggest and most surprising one for scientists wasmitochondrial dysfunction. Mitochondria play a critical role in producing the chemical energy necessary to keep cellsand by extension, tissue and organsfunctional. Researchers found irregular mitochondrial performance in dozens of astronauts and were able to broadly characterize these changes thanks to new genomics and proteomics techniques. Afshin Beheshti, a bioinformatician at NASA and senior author of one study, says mitochondrial suppression helps explain how many of the problems astronauts experienced (like immune system deficiencies, disrupted circadian rhythm, and organ complications) are actually holistically related to each other, since they all rely on the same metabolic pathways.

When youre in space, its not just one are or organ thats affected, its the whole body thats affected, says Beheshti. "We started connecting the dots."

Other research homed in on problems observed at the genetic level. The Twins Study showed that Kellys telomeres got longer in space before shrinking back to normal or even shorter lengths soon after he returned to Earth. Telomeres are supposed to shorten with age, so lengthening makes little sense, and the Twins Study didnt provide enough data to prompt any real conclusions as to why it happened and what the effects were.

Susan Bailey, a Colorado State University expert on telomere research and a senior author for several of the papers, says the new research found that 10 other astronautsexperienced the same telomere lengthening Kelly did irrespective of mission durationas well as the same telomere shrinking once they came back to Earth.

Notably, one of the papers in the new package found that longer telomeres were also associated with climbers of Mount Everest. For Bailey and her colleagues, this suggests that telomere lengthening isaffected by oxidative stresssomething that climbers and astronauts both experience, and that disrupts proper telomere maintenance.

NASA

They are still trying to pinpoint how these pathways work and exactly what the consequences could be (its probably not a secret to longevity), but we now have a foundation to build onwe know what to look for and be aware of in future astronauts on long-duration [and deep space] exploration missions, she says.

Though some of the changes are unexpected, many are no cause for concern. What is amazing to me is how well we adapt to space, says Jeffrey Sutton, director of the Baylor College of Medicines Center for Space Medicine, who was not involved with the new research.Blood cell mutations decreased in Kelly while he was in space(a total surprise for Mason). Astronauts also exhibiteddecreased levels of biomarkers associated with agingandincreased levels of microRNAsthat regulate the vascular systems response to radiation damage and microgravity. One of the strangest findings was that astronauts gut microbiomes managed to bring space microbes found on the ISS back to Earth.

The studies individually and collectively are truly impressive, says Sutton. We have entered a new era of space biomedical research, where the approaches and tools of precision and translational medicine are being applied to advance our understanding of human adaptation to space.

Ultimately, however, the data highlights just how much havoc and stress even the healthiest bodies face during space missionswhich should have an impact on planning for longer missions. I dont think were close to sending untrained people into space for really long periods of time, says Scott Kelly.

Physiologically, he thinks its probably safe to send people to Mars and back. In the distant future, however, instead of going to Mars, were going to be going to the moons of Jupiter or Saturn, he says. Youre going to be in space for years. And at that point, well have to take a closer look at artificial gravity as a mitigation. I wouldnt want to be arriving on the surface of another planetary body and not be able to function. A year or so is workable. Several years probably isnt.

NASA

Were still far away from having to evaluate those kinds of risks. Mason and his colleagues suggest that there should be pharmacological strategies for reducing the impact of gravity on the bodies of returning astronauts.

Sutton believesprecision medicinecould play a huge role in tailoring those drugs to protect astronauts against the effects of microgravity and radiation. And the shared biological responses between astronauts and Mount Everest climbers suggest that some interventions used to protect extreme sports athletes from oxidative stress could be applied to astronauts too.

What we need is more dataand more populations to use for comparison. Mason, Bailey, and their colleagues are starting to collect cell and gene profiles of more astronauts, especially those going on future year-long missions. They also want to study people whove experienced other conditions similar in some way to spaceflight, such as radiotherapy patients, pilots, and flight attendants.

The more we know about the health effects of long-duration spaceflight, the better able we will be to help maintain the health and performance of astronauts during and after spaceflight, says Bailey. Such knowledge benefits those of us on Earth as wellwe are all concerned about getting older, and being in poor health.

This post has been updated with comments from Afshin Beheshti.

Read this article:
Spaceflight does some weird things to astronauts bodies - MIT Technology Review

Read More...

Precision Medicine Software Market 2020: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19 Impact | Top…

Monday, November 30th, 2020

Precision Medicine Software Marketis anticipated to discover Robust Growth by 2026. This report focuses on the leading key players with global perspective with a professional and in-depth study on the current state of Precision Medicine SoftwareIndustry. Precision Medicine Softwaremarket research report provides important market strategies and Latest trends with discussion of market consumption, major drivers, restraints and market share forecasted to 2026.

The Precision Medicine Software Market Report further describes detailed information about tactics and strategies used by leading key companies in the Precision Medicine Softwareindustry. It also gives an extensive study about different market segments and regions.

The Precision Medicine Softwaremarket report provides answers to the following key questions:

To get more information, Ask for Sample PDF:https://inforgrowth.com/sample-request/6461601/precision-medicine-software-market

The Precision Medicine SoftwareMarket report provides basic information about Precision Medicine Softwareindustry, definition, classification, application, industry chain structure, industry overview; international market analysis. This report studies sales (consumption) of Precision Medicine Softwaremarket, focuses on the top players, with sales, price, revenue and market share with volume and value for each region.

Top Key Players in Precision Medicine Softwaremarket: Syapse, , Allscripts, , Qiagen, , Roper Technologies, , Fabric Genomics, , Foundation Medicine, , Sophia Genetics, , PierianDx, , Human Longevity, , Translational Software, , Gene42, Inc, , Lifeomic Health

Precision Medicine SoftwareMarket on the basis of Product Type:Cloud-based, , On-premise

Precision Medicine SoftwareMarket on the basis of Applications:Healthcare Providers, , Pharmaceutical and Biotechnology Companies, , Research Centers and Government Institutes, , Others,

Get up to 30% instant discount Under Our Thanksgiving Discount OFFER;https://inforgrowth.com/discount/6461601/precision-medicine-software-market

Impact of COVID-19:

Precision Medicine SoftwareMarket report analyses the impact of Coronavirus (COVID-19) on the Precision Medicine Softwareindustry.Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Precision Medicine Softwaremarket in 2020.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Get the Sample ToC and understand the COVID19 impact and be smart in redefining business strategies.https://inforgrowth.com/CovidImpact-Request/6461601/precision-medicine-software-market

Key Questions Answered in this Report:

What is the market size of the Precision Medicine Softwareindustry?This report covers the historical market size of the industry (2013-2019), and forecasts for 2020 and the next 5 years. Market size includes the total revenues of companies.

What is the outlook for the Precision Medicine Softwareindustry?This report has over a dozen market forecasts (2020 and the next 5 years) on the industry, including total sales, a number of companies, attractive investment opportunities, operating expenses, and others.

What industry analysis/data exists for the Precision Medicine Softwareindustry?This report covers key segments and sub-segments, key drivers, restraints, opportunities, and challenges in the market and how they are expected to impact the Precision Medicine Softwareindustry. Take a look at the table of contents below to see the scope of analysis and data on the industry.

How many companies are in the Precision Medicine Softwareindustry?This report analyzes the historical and forecasted number of companies, locations in the industry, and breaks them down by company size over time. Report also provides company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness and market capitalization.

What are the financial metrics for the industry?This report covers many financial metrics for the industry including profitability, Market value- chain and key trends impacting every node with reference to companys growth, revenue, return on sales, etc.

What are the most important benchmarks for the Precision Medicine Softwareindustry?

Is there any query? Ask to our Industry Expert: https://inforgrowth.com/enquiry/6461601/precision-medicine-software-market

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898

See the rest here:
Precision Medicine Software Market 2020: Potential growth, attractive valuation make it is a long-term investment | Know the COVID19 Impact | Top...

Read More...

Genetics and Alcohol Use Disorder: 5 Things You Should Know – Longevity LIVE

Saturday, November 7th, 2020

The Penn Medicine team identified 18 genetic variants that are related to either heavy alcohol consumption, alcohol use disorder, or both. Five of these variants overlapped, while eight were associated solely with heavy alcohol consumption. Another five were traced with alcohol use disorder only.

One finding from the study was that, although heavy drinking is a prerequisite for alcoholism, variants for particular genes may predispose someone towards alcoholism. Examples of gene variants cited by the Penn Medicine researchers are DRD2 and SIX3. This finding is important because identifying these gene variants in a person may help medical professionals better ascertain their risk for alcohol use disorder.

Ultimately, paying attention to the genetic aspect of a persons alcohol use disorder may contribute to their treatment. There are ongoing studies about patients receptiveness to certain medications for treatment, based on their genes.

For example, naltrexone is a drug thats commonly used to treat dependence on alcohol, as well as opiates. In research cited by the NIAAA, it was found that patients with a specific gene variation responded positively to naltrexone treatment. Those who didnt have the gene, however, did not. In the future, this kind of information may factor into the accuracy and responsiveness of medical treatment for alcohol addiction.

Conclusion: Unlocking Important New Knowledge about Genetics and Alcohol Addiction

Though the relationship between genes and alcoholism has been under scrutinous scientific study for some time, it isnt always common knowledge to laymen. But not being able to see the bigger picture of what contributes to alcoholism may allow certain myths about it to prevail. Many people may still believe that alcohol addiction is 100% a personal choice. But as the information above about genetics and alcohol use disorder portray, its never that simple.

In any case, whether genes influence someones predisposition to alcohol use disorder, no attempt at healing from it is a futile one. Be both compassionate and knowledgeable when approaching the issue of alcoholismbecause your support could save a life.

The rest is here:
Genetics and Alcohol Use Disorder: 5 Things You Should Know - Longevity LIVE

Read More...

Adrenomyeloneuropathy Treatment Market Covid-19 Impact On In-depth Industry Analysis: Ascend Biopharmaceuticals, Immatics Biotechnologies, Human…

Saturday, November 7th, 2020

The report on the Global Adrenomyeloneuropathy Treatment Market has been prepared after conducting a comprehensive research through a systematized methodology. These skills are useful for scrutinizing the market on the terms of outlined research guidelines. Mainly, global Adrenomyeloneuropathy Treatment market research report covers all the information about the target audience, manufactures, vendors, research papers, products and many more. Keeping a focus on the overall market aspects, and perceptions, this report vastly covers profiles of the companies who have made it big in this particular field along with their sales data and other data. It also suggests the business models, innovations, growth and every information about the big manufacturers that will be present the future market estimates. Every market consists of set of manufacturers, vendors and consumers that gives a definition to the market, its each and every move, achievements. All these are the important subjects required to study the analysis of the global Adrenomyeloneuropathy Treatment market.

Get sample copy of Adrenomyeloneuropathy Treatment Market report @ https://www.orbispharmareports.com/sample-request/44669

It also includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. In addition, this report offers significant data through the SWOT analysis, investment return data, and investment feasibility analysis. The global Adrenomyeloneuropathy Treatment market report also features a comprehensive quantitative and qualitative evaluation by analysing information collected from market experts and industry participants in the major points of the market value chain.

Major Company Profiles operating in the Adrenomyeloneuropathy Treatment Market:

Ascend BiopharmaceuticalsImmatics BiotechnologiesHuman LongevityNovadip BiosciencesBioRestorative TherapiesEureka TherapeuticsCytori TherapeuticsAllogene TherapeuticsRegeneusNewLink GeneticsTalaris Therapeutics

By the product type, the market is primarily split into:

Steroid Replacement TherapyStem Cell Transplant

By the application, this report covers the following segments:

HospitalsClinicsAmbulatory Surgical CentersOthers

The data offered in global Adrenomyeloneuropathy Treatment market report is gathered based on the latest industry news, trends, as well as opportunities. This study offers a separate analysis of the major trends in the existing market, mandates and regulations, micro macroeconomic indicators is also comprised in this report. By doing so, the study estimated the attractiveness of every major segment during the prediction period.

Browse the complete report @ https://www.orbispharmareports.com/covid-19-impact-on-2020-2026-global-and-regional-adrenomyeloneuropathy-treatment-industry-production-sales-and-consumption-status-and-prospects-professional-market-research-report-standard-version/

Moreover, the report comprises the analysis of opportunities available in the Adrenomyeloneuropathy Treatment market on the global level. It also includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. The annual progression for the global Adrenomyeloneuropathy Treatment market in different regions cannot always be listed down as it will keep changing, thus studying and reviewing markets occasionally becomes vital.

In addition, the Adrenomyeloneuropathy Treatment market report provides a detailed information about the key market players along with the strategies they implemented to gain market existence and develop themselves. The report includes precise market estimations depending on current market status and future market forecasts.

For Any Query on the Adrenomyeloneuropathy Treatment Market: https://www.orbispharmareports.com/enquiry-before-buying/44669

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.+1 (972)-362-8199[emailprotected]

See original here:
Adrenomyeloneuropathy Treatment Market Covid-19 Impact On In-depth Industry Analysis: Ascend Biopharmaceuticals, Immatics Biotechnologies, Human...

Read More...

Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 – Stock Market Vista

Saturday, November 7th, 2020

There are millions of them around the globe waiting for clutching on to some of the latest vital information circulating across the globe. The up-to-the-minute AI Medicine Software market report based on the growth and the development of theAI Medicine Software marketis systematically listed down. The AI Medicine Software market report comprises statistically verified facts such the unique essence including topological investigations, worldwide market share, government stringent norms, applications, current trends, futuristic plans, market bifurcations, and so on mentioned in a crystal clear pattern.

The statistical plus scientific AI Medicine Software market report has all the important market aspects penciled down in a layman language format so that the data based on the markets productivity or future strategy can be easily extrapolated from the reports. The AI Medicine Software market report has the dominant market players Tempus Labs, Inc., Flatiron Health, Inc., Gene42, Inc., Sunquest Information Systems Inc, 2bPrecise LLC, NantHealth, Inc, IBM Watson Group, Human Longevity, Inc., N-of-One, Inc., Translational Software, Inc, SOPHiA GENETICS SA, Syapse, Inc., LifeOmic Heal explained in detail.

Sample of global AI Medicine Software Market Report at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#RequestSample

The essential futuristic segments such as {Machine Learning, Natural Language Processing, Others}; {Drug Discovery, Precision Medicine, Others} have also been detailed out in the AI Medicine Software market report for the clients convenience and more of vital data embracing capability. The forecast trends along with the current market status can better understand the AI Medicine Software market development on a global basis. The intricate industrial strategies and the supply-demand chain are also discussed in the contextual report.

Key points of the global AI Medicine Software market

Theoretical analysis of the global AI Medicine Software market stimulators, products, and other vital facets Recent, historical, and future trends in terms of revenue and market dynamics are reported Pin-point analysis of the competitive market dynamics and investment structure is predicted to grow Future market trends, latest innovations, and various business strategies are reported Market dynamics include growth influencers, opportunities, threats, challenges, and other crucial facets

The AI Medicine Software market report has the imperative data mentioned in a systematic way only after comprehensive inspection and vigilant referencing. The diagrammatic representations such as a pie chart of the AI Medicine Software market are also drawn out so as to attract the punters and make it easy for them to comprehend the entire AI Medicine Software market from in and out. The most eye-catching format of the AI Medicine Software market report is its market bifurcation based on the product type, application, geography, end-users, and more as per the particular market. The geographical segments Europe, North America, Latin America, Asia Pacific, and Middle East & Africa are further exhaustively mentioned.

Read Detailed Index of full Research Study at::https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259

Questions answered in the report include

1. What is the expected market size by the end of the forecast period?2. What are the major factors initiating the global AI Medicine Software market growth?3. What are the latest developments and trending market strategies that are influencing the growth of the AI Medicine Software market?4. What are the key outcomes of the AI Medicine Software market developments?5. Who are the key players in the market?6. What are the opportunities and challenges faced by the key players?

The AI Medicine Software market report endows the global market dominance, market segmentation, growth factors, and others reported such that the clients can have a total tour of the market without any much off efforts needed.

Key Reasons for Purchasing Global AI Medicine Software Market Report

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities

Ask Any Kind of Query Before Purchasing the Report Here:https://www.marketresearchstore.com/report/global-ai-medicine-software-market-report-2020-industry-761259#InquiryForBuying

View post:
Global AI Medicine Software Market Analysis of Key Players, Type, Application, Demand and Consumption By 2026 - Stock Market Vista

Read More...

Global Obesity Treatment Market Incredible Potential Examined in New Research Report – The Think Curiouser

Saturday, November 7th, 2020

Global Obesity Treatment Market: Overview

Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers.

Obesity treatment basically incorporates a two-step process: assessment and management. Obesity assessment includes determination of the level of obesity and obesity management involves overall maintenance of body weight as well as the systematic weight loss programs.Government initiatives to increase the awareness about fitness, technological advancements improving the compliance rates of surgeries, and aggressive marketing strategies to attract customers are some of the drivers for the growth of the obesity treatment market.

Factors responsible for restraining the growth of the obesity treatment market are availability of low cost alternatives, high cost of customization, and post-surgical side effects.

Request Brochure for Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18497

Global Obesity Treatment Market: Notable Developments

The obesity treatment market is segmented based on lifestyle changes, surgical & implant devices, and medication therapy. Lifestyle changes involves dietary changes and exercise. The dietary segment held a significant share in 2015 and is expected to increase during the forecast period. The reasons for the projected growth of the segment might be low cost of therapy, increase in health consciousness among people, and acceptance of the fact that it is easier to lower calorie intake to a greater degree than to burn more calories through increased exercise.

The surgery & implant devices are further categorized into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation system, and gastric emptying system. Gastric bypass surgery is a fast growing segment in the obesity treatment market owing to factors such as fast recovery time, improved psychological status, and improved longevity. The minimally invasive segment is expected to grow at a higher rate during the forecast period due to its reversible nature, rapid effect, and cost & time effectiveness. It basically involves employing the implant devices in gastric area, which minimizes the incidences of post-operative infections that arise from invasive procedures. It in turn shortens the hospital stays for patients.

Request for Analysis of COVID19 Impact on Obesity Treatment Market:

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18497

Global Obesity Treatment Market: Key Trends

The surgery & implant devices are further categorized into gastric bypass surgery, gastric balloon, gastric band, electrical stimulation system, and gastric emptying system. Gastric bypass surgery is a fast growing segment in the obesity treatment market owing to factors such as fast recovery time, improved psychological status, and improved longevity. The minimally invasive segment is expected to grow at a higher rate during the forecast period due to its reversible nature, rapid effect, and cost & time effectiveness. It basically involves employing the implant devices in gastric area, which minimizes the incidences of post-operative infections that arise from invasive procedures. It in turn shortens the hospital stays for patients.

In medication therapy, the individual (satiety) drug and combination drug therapy are the two major segments. The combination drug segment in the obesity treatment market captured a large share globally in 2015. It is mainly attributed to the synergistic effect of combined therapy in obesity treatment and rising prevalence of obesity. The satiety drug which provide a feeling of gastric fullness is a fast growing segment in the obesity treatment market. The major reason for the growth is its cost which is lower than that of the combination therapy.

Key Players of Obesity Treatment Market Report

Key market players operating in the obesity treatment market include NutriSystem, Inc. (U.S.), Kellogg Company (U.S.), Ethicon, Inc. (U.S.), Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), Olympus Corporation (Japan), Brunswick Corporation (U.S.), and Technogym SpA (Italy). Increase in focus of the market players on gaining FDA approvals to launch new drugs and devices in the obesity treatment market propels the growth of the obesity treatment market exponentially during the forecast period.

Buy Obesity Treatment Market Report

https://www.transparencymarketresearch.com/checkout.php?rep_id=18497&ltype=S

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Continued here:
Global Obesity Treatment Market Incredible Potential Examined in New Research Report - The Think Curiouser

Read More...

Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -…

Saturday, November 7th, 2020

New Market Research Report: on Adrenomyeloneuropathy Treatment Market size | Segment by Applications (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Type (Steroid Replacement Therapy and Stem Cell Transplant), Regional Outlook Opportunity, Market Demand, Latest Trends, Adrenomyeloneuropathy Treatment Industry Share & Revenue by Manufacturers, Leading Companies Profiles, Analysis, Growth Forecast 2025. Analyzes current market size and upcoming Few years' growths of this industry.

Adrenomyeloneuropathy Treatment Market Size report is the best source that gives CAGR values with variations during the forecast period of 2020-2025 for the market. The study encompasses market drivers and restraints by using SWOT analysis, along with their impact on the demand over the forecast period. This global market report endows with a profound overview of product specification, product type, production analysis, and technology by taking into consideration the major factors such as revenue, cost, and gross margin. The Adrenomyeloneuropathy Treatment advertising report has been prepared based on the market type, size of the organization, availability on-premises, and the end-users organization type.

Some of the prominent players operating in the global Adrenomyeloneuropathy Treatment market include Ascend Biopharmaceuticals, Immatics Biotechnologies, Human Longevity, Novadip Biosciences, BioRestorative Therapies, Eureka Therapeutics, Cytori Therapeutics, Allogene Therapeutics, Regeneus, NewLink Genetics and Talaris Therapeutics among others.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/240610

Competitive Analysis: Adrenomyeloneuropathy Treatment Market

Global Adrenomyeloneuropathy Treatment market Size is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Adrenomyeloneuropathy Treatment market Share for global, Europe, North America, Asia-Pacific, South America, and Middle East & Africa.

Global Adrenomyeloneuropathy Treatment Market Split by Product Type and Applications:

Based on Types:

Based on Application:

The latest research on the Adrenomyeloneuropathy Treatment Market Size fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Adrenomyeloneuropathy Treatment Market for the forecast period, 20202025. To help firms comprehend the Adrenomyeloneuropathy Treatment industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.

Report Highlights:

The report covers the shifting industry dynamics

Detailed information about the market segmentation

Covers past, present and projected industry size Recent industry trends

Key Competition landscape

Business strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards market performance

Queries Resolved In This Report:

Which will be the specialties at which Adrenomyeloneuropathy Treatment Market players profiling with intensive designs, financials, and ongoing headways should set nearness?

Which will be the foreseen development rates for your own Adrenomyeloneuropathy Treatment economy out and out and each portion inside?

Which will be the Adrenomyeloneuropathy Treatment application and sorts and estimate joined intently by makers?

Which will be the dangers which will attack growth?

The length of the global Adrenomyeloneuropathy Treatment market opportunity?

How Adrenomyeloneuropathy Treatment Market share advance vacillations of their value from various assembling brands?

Chapters Define in TOC (Table of Content) of the Report:

Chapter 1: Market Survey, Drivers, Restraints and Good fortune, Segmentation overview

Chapter 2: Market competitiveness by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Overall profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses

Chapter 9: Supply Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Influence Factors Analysis

Chapter 12: Market Predict

Chapter 13: Adrenomyeloneuropathy Treatment Research Findings and Conclusion, Appendix, methodology and data source

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/240610

Go here to see the original:
Global Adrenomyeloneuropathy Treatment Market Size, Share, Trends, CAGR by Technology, Key Players, Regions, Cost, Revenue and Forecast 2020 to 2025 -...

Read More...

Early Evidence Shows Fasting, Keto Diet May Make Chemo and Some Other Cancer Treatments More Effective and Easier to Tolerate – Curetoday.com

Saturday, November 7th, 2020

Jocelyn Aguilar felt bad enough after the first of a scheduled four rounds of chemotherapy that she thought about quitting.

She had no detectable cancer after undergoing double mastectomy for breast cancer, so the chemotherapy was an optional treatment that Aguilar, age 37 when diagnosed in October 2019, had chosen to reduce the risk of recurrence.

She ultimately decided to continue because, starting with her next round of chemotherapy, she was going to help test a counterintuitive-but-promising strategy for reducing chemotherapys side effects and increasing its cancer-fighting power: a very low-calorie diet designed to mimic the effects of fasting.

On weeks (when) I was due to receive chemo that Friday, I got four boxes of food labeled Tuesday, Wednesday, Thursday and Friday. The only food I ate those days came from that days box. On Saturday morning, I woke up and eased myself back into normal eating, says Aguilar, a nurse who works at the University of Southern California (USC), where the trial took place.

The pain I experienced with that first round of chemo, before the fasting, was so terrible that I didnt think I could go on, says Aguilar, who described the sensation as aches and pains all over her body. With the fast, there were still some effects, but they were not nearly as bad. It was a huge difference.

Aguilar says that her food boxes each contained about 300 calories worth of plant-based food. The diet is billed by its distributor as containing micro- and macronutrients that are nourishing but not recognized as food by the body, which mimics fasting.

Its hard to imagine a more counterintuitive cancer treatment than fasting why deprive the body of vital nutrients when it would seem to need them most? but a growing body of research suggests that fasting decreases the toxicity of cancer treatments and may increase their efficacy too.

Some evidence also shows that a ketogenic diet, which deprives the body of carbohydrates rather than all calories, may increase the efficacy of some cancer treatments. In fact, there is even some thought that the two diets may help prevent cancer, although evidence for this is currently limited.

When it comes to supplementing cancer therapies, the benefits of either dietary intervention also have yet to be definitively proven unless youre a mouse. The animal data for fasting, which started in our lab but is now coming from many labs, is extraordinary. Its hard to think of anything in the past, ever, that has done better, says Valter Longo, who holds a doctorate in biochemistry and is the Edna M. Jones Professor of Gerontology and Biological Sciences and the director of the Longevity Institute at the USC Leonard Davis School of Gerontology.

Healthy cells and tumor cells respond differently to fasting. Healthy cells shut down their growth-promoting pathways shortly after the food stops coming in and focus on cell repair. Cancer cells, on the other hand, rarely slow their unrestrained growth enough to engage in this self-protective behavior.

Fasting thus increases the ability of healthy cells to withstand stressors such as chemotherapyor radiotherapy, but it leaves cancer cells, which suddenly have less nutritional support to sustain their rapid growth, unusually weak and vulnerable.

Fasting also depletes stored carbohydrates. Normal cells can adapt to this by running mostly on two fat-derived energy sources fatty acids and ketones but cancer cells are far more reliant on sugars, starches and the insulin that drives them into cells.

Most of the mouse studies to date have assessed fastings effect on chemotherapy or radiotherapy, but at least one study has found that a low-calorie fasting- mimicking diet (FMD) plus simple vitamin C can slow the progression of KRAS-mutated colon cancer. Another study, this one published in the prestigious journal Nature, found that both fasting and a FMD increased and extended the efficacy of the hormonal treatments tamoxifen and Faslodex (fulvestrant) in mouse models of hormone-receptor-positive breast cancer.

The first clinical trial of short-term fasting in humans, which was published in 2009, reported results in 10 patients with various types of cancer. It found that fasting reduced chemotherapy-related toxicities fatigue, weakness and gastrointestinal side effects in the six patients who fasted 48 to 140 hours before and five to 56 hours after some (but not all) of their chemotherapy sessions.

Several other trials in humans, all of them following small patient populations for short periods of time, have also found that fasting reduced treatment-related toxicities such as fatigue or DNA damage in healthy cells. For example, one Dutch trial assigned six patients with breast cancer to follow normal dietary guidelines and seven others to fast 24 hours before and after chemotherapy. Nonhematological toxicity did not differ between the two groups, but the researchers found evidence that fasting reduced bone marrow toxicity and reduced chemotherapy-induced DNA damage in some healthy blood cells.

Data from several of these small trials also suggested that fasting increased treatment efficacy, but none of them were large enough (or lasted long enough) to prove that fasting extended patients survival. There is even less evidence to support the use of fasting or the ketogenic diet in combination with immunotherapy treatments, although that remains a tantalizing possibility.

The only large trial in humans to have reported results so far was inconclusive for a somewhat unexpected reason.

Investigators randomly assigned 131 Dutch women, all of whom were slated to receive chemotherapy for stage 2/3 HER2-negative breast cancer, either to eat according to standard guidelines or to follow the FMD. Sixty-six of the women were assigned to follow the FMD but, unfortunately, so few actually complied that it was impossible to evaluate the diets effects. Just 32% of women in the fasting group fasted before at least half of their chemotherapy cycles, and just 24% of them fasted before all of them.

Patient noncompliance was particularly disappointing because the FMD was designed by Longo who has a financial interest in a company that sells FMD meal kits as a less demanding way to get all the effects of a true, zero-calorie fast.

It wasnt easy, says Aguilar, but it was doable. Im not normally a healthy eater, and I was being given steroids at the time, so my appetite was out of control, but I still managed it because it reduced the pain so much.

Hopefully, patients in several other large studies, all of which are nearing their scheduled completion dates, will comply with fasting protocols well enough to help researchers determine whether short-term fasting can extend life, reduce treatment toxicity or both for patients with glioblastoma, non-small cell lung cancer, lung adenocarcinoma, ovarian cancer, breast cancer and colorectal cancer.

Positive results could change standards of care for all those tumor types within the next couple of years.

For patients who cant wait that long to select their treatment plan, the obvious question is whether they should ask their oncologists about starting now with short- term fasts or the FMD.

Some experts believe its too early to use fasting anywhere outside of clinical trials.Indeed, a group of Italian clinicians recently published a letter in Nature Reviews Cancer that cautioned against what they perceive as excessive enthusiasm about fastings potential benefits and insufficient caution about its potential to harm some patients.

It is worrying that the application of fasting in oncology has been prematurely reported by the media as a potential advance in medical oncology, to the point where FMD kits have recently been commercialized, the clinicians wrote. These may negatively interfere with cancer care, as patients at risk of malnutrition or sarcopenia (muscle loss) could autonomously decrease protein-calorie intake during treatment.

Longo agrees that neither malnourished patients nor those who are responding to their current treatment should try fasting or the FMD outside of clinical trials. However, he believes the data from both animal models and early human trials are strong enough to make fasting an option when approved treatments stop working.

I think (the evidence so far) is enough for an oncologist to say, Look, your therapy isnt working. Im out of options here. This fasting-mimicking diet is so effective in mice. Why dont we give it a shot? You have to understand there are risks, but you also have to understand that were out of options. That conversation would be appropriate now, Longo says.

Fasting isnt the only way to drive blood sugar and insulin down. Patients can achieve nearly equivalent reductions by following a ketogenic diet that provides about 80% of calories from fat, 12% from protein and 8% from carbohydrates.

Low sugar consumption means low blood sugar, which, in turn, means low levels of insulin a hormone secreted by the pancreas to drive sugar into muscles and fuel their growth and/or activity. Healthy tissue, as mentioned before, can adapt to deriving nearly all its energy fromfat, although many people feel pretty drained for a week or so at the beginning of that adjustment. (This lousy feeling is known as keto flu.) Many tumors, on the other hand, seem far less able to overcome their dependence on insulin and sugar (aka glucose).

Weve known for 100 years that cancer cells take up glucose at a much higher rate than do the normal tissues from which those cancer cells emerge, says Lewis Cantley, who holds a doctorate in biophysical chemistry and is the Meyer Director of the Sandra and Edward Meyer Cancer Center and a professor of cancer biology in medicine at Weill Cornell Medical College.

This does not mean that patients can starve their tumors to death simply by following ketogenic diets, but it has led many researchers to speculate that adding a ketogenic diet to standard treatment protocols might increase the efficacy of many of those regimens.

It has been difficult to test this theory, however. Because no pharmaceutical company canpatent a ketogenic diet, no one has a financial incentive to spend the millions of dollars that largestudies cost. Instead, studies get funded through the National Institutes of Health and foundation grants. Tests of FMDs face the same issue.

The ketogenic diet also runs into the same problem that makes it hard to test fasting: patient compliance. Indeed, researchers who work for the Department of Veterans Affairs in Pittsburgh enrolled 11 patients with cancer in a 16-week trial of the ketogenic diet. Only four of them actually followed the diet all 16 weeks.

In spite of the challenges, several recent discoveries suggest that ketogenic diets may be particularly helpful for certain cancer treatments helpful enough to drive funding and convince patients to follow the diet.

Cantley discovered a previously unknown link between sugar, insulin and cancer growth more than three decades ago: an enzyme called phosphoinositide 3-kinase (PI3K) that helps drive sugar into cells. Mutations in the genes that regulate PI3K causing an increase in PI3K activity are among the most common of all cancer mutations.

His discovery eventually led to the creation of PI3K- inhibiting medications, three of which have been approved for the treatment of several cancers. But all three have a big drawback.

When you give patients a PI3 kinase inhibitor, which hits the same enzyme that propagates the insulin response, you get the unsurprising result that the patient instantly becomes insulin resistant. Many of the patients in the trials of these drugs had to drop out because of high blood sugar, Cantley says.

Extra insulin, whether created by the body in response to rising blood sugar or deliberately injected, will solve the problem by driving the sugar into muscles, but it also drives sugar into tumors and destroys treatment efficacy.

Cantleys team hypothesized that PI3K inhibitors would be far safer and more effective if used in combination with some tool that would control blood sugar without driving it into tissues. They saw dramatically improved results in mice when they paired PI3K inhibitors with a class of diabetes medications called SGLT2 inhibitors, which reduce the bodys absorption of glucose via the kidneys so that excess glucose is excreted through the urine. Results were better still when they fed mice a ketogenic diet.

Blood sugar levels hardly went up. Insulin levels hardly went up. Tumors melted away, says Cantley, who also has a financial interest in a company that makes prepackaged meals for patients with cancer. Every tumor we tried essentially disappeared whenever we gave a PI3 kinase inhibitor with a ketogenic diet.

A large human trial will compare the current standard for using PI3K inhibitors against treatment plans that combine PI3K inhibitors with either SGLT2 inhibitors or a ketogenic diet. The ongoing global pandemic delayed the trial for several months, but enrollment has now begun.

And its not the only trial thats testing the ketogenic diets effect on cancer treatments. At least 18 other such studies are either recruiting patients or preparing to do so.

The whole thing comes down to energy. Without energy, nothing can grow, says Thomas N. Seyfried, who holds a doctorate in genetics and biochemistry and is a biology professor at Boston College who studies how metabolic therapies such as a ketogenic diet can affect cancer and other diseases. Tumor cells make energy by fermenting glucose and the amino acid glutamine. If we restrict the availability of glucose and glutamine, this will create tremendous metabolic stress on the tumor cells.

For more news on cancer updates, research and education, dont forget tosubscribe to CUREs newsletters here.

Read more:
Early Evidence Shows Fasting, Keto Diet May Make Chemo and Some Other Cancer Treatments More Effective and Easier to Tolerate - Curetoday.com

Read More...

Healthcare Business Process Outsourcing Market 2020 Global Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025 – Zenit…

Saturday, November 7th, 2020

Researchmoz Presents Healthcare Business Process Outsourcing Market Size, Status and Forecast 2020-2026 New Document to its Studies Database

This report, which has been published, is having a meaningful Healthcare Business Process Outsourcing market insight. It casts some lights on industry products and services. Along with those product applications, it also examined whether it reaches up to the end-users or not. This report on this Healthcare Business Process Outsourcing market has given an overall view of the recent technologies used and technological improvements. It also focuses on recent industry trends and which products are quite demanding from a customers perspective. This report is focused on every aspect of the forecast year 2026.

Healthcare Business Process Outsourcing Market dynamics analysis

This report is representing a whole market scenario on a global basis. In this report, we can also find the analysis growth of industries. Through this report, we can easily interpreter the level of market competition, different pricing models, the latest market trends, customer demand, etc. This report acknowledges the revenue model and market expansion of this Healthcare Business Process Outsourcing market. If you want to get that full market information, then this report can help you. It also gives a comprehensive knowledge about the demand and supply graph. Suppose that demand curves moved downward, then from this report, you can know about those factors responsible for its decline. Accordingly, you can know the responsible factors for the rising curve. This Healthcare Business Process Outsourcing market report gives a total knowledge about the market trend and improves its strategies and pricing model.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2812408&source=atm

In the competitive analysis section of the report, leading as well as prominent players of the global Genomic Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyBio-RadBeckman CoulterMyriad GeneticsThermo Fisher ScientificRocheQIAGENEpigenomicsAlmacPfizerHuman LongevityValiRxPersonalisEagle GenomicsEmpire GenomicsAgilentIllumina

Research and Methodology

For the research, the Healthcare Business Process Outsourcing markets research teams are adopted various high-end techniques. Industry best analysts are worked on this report. They collected data from various reliable sources and have taken samples of different market segments. They utilize both qualitative and quantitative data in this report. All data are based on primary sources, which are focused on the assessment year 2020-2026. For wise decision-making, they have also done SWOT analysis, which can also help them know their predicted future results. This report also helps to develop Healthcare Business Process Outsourcing market growth by improvising its strategic models.

segment by Type, the product can be split intoOncologyCardiologyNeurologyNephrology

Market segment by Application, split intoHospitalsDiagnostic and research laboratories

Based on regional and country-level analysis, the Genomic Biomarker market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

Regional and Country-level Analysis

The Healthcare Business Process Outsourcing market is analysed and market size information is provided by regions (countries).

The key regions covered in the Healthcare Business Process Outsourcing market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2812408&licType=S&source=atm

Table Of Content Covered In this Healthcare Business Process Outsourcing Market Report:

1 Report Overview

2 Global Growth Trends by Regions

3 Competition Landscape by Key Players

4 Breakdown Data by Type (2015-2026)

5 Breakdown Data by Application (2015-2026)

6 North America

7 Europe

8 China

9 Japan

10 Southeast Asia

11 India

12 Central & South America

13Key Players Profiles

14Analysts Viewpoints/Conclusions

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details

Read the original:
Healthcare Business Process Outsourcing Market 2020 Global Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2025 - Zenit...

Read More...

Turning the Tide – Lifestyle Medicine and change (part 7) – South Coast Herald

Sunday, October 25th, 2020

Last week we presented common excuses given for why we dont want to commit to changing our behaviour and adopting a healthier way of living.

Today we will cover more ground.

It is true. There are some people who live the most atrociously unhealthy lives who seem to fly under the radar, and escape the bullets. In spite of all odds, they make it to a ripe old age. Good luck to them. But the chance you will do likewise is remote.

ALSO READ : Turning the Tide Top tips on how to change your diet for the better

There are many factors that may have contributed to his longevity genetics, a more active younger life, getting enough sleep at night, a positive attitude towards life, eating some natural whole foods, even if it is a tin of baked beans from time to time. One gets these outliers, who beat the odds.

But instead of stacking up the odds against you, why not try to reduce the risks by whittling away at factors that have been scientifically proven to reduce your health and vitality. And in the process you can reap the rewards of feeling so much better within days of adopting change.

I agree it can be confusing. Author Michael Pollan said Eat food, not too much, mostly plants. Too much of what we eat is food-like substances highly processed edible concoctions that have a long list of very scientific-sounding ingredients. The best foods are the ones that dont have ingredient lists the ones you buy in the vegetable and fruit sections of the supermarket. For thousands of years humankind has thrived on natural foods fruits, vegetables, whole grains, legumes and nuts, seeds and spices. It is only in the last century that the industrial revolution has introduced factory-altered foods to make them more palatable, addictive and provide a longer shelf-life. In doing so our food has lost a great deal of the natural goodness fibre, phytochemicals, vitamins, minerals, etc.

His second point is also relevant not too much. When the food has been so concentrated and titillated, it is easy to over-indulge, resulting in excessive energy intake. This is one of the main reasons for the obesity epidemic.

If we eat mostly plants, we will not be exposed to high levels of saturated fats, and excessive proteins, heme-iron, inflammatory stimulators, hormones and growth stimulators so rife in animal products.

The media loves controversy it sells newspapers/magazines. We love to get good news about our bad habits.

So when some study or article makes claims that support peoples bad habits, even when the study has been sponsored by the industries who benefit most from the recommendations, the headlines are all over the place, creating confusion and controversy. There is more than enough very sound research supporting the simple nutritional information we present in this blog, and which has become imbedded in most of the national guidelines around the world.

There are very many challenges in life. If we want to achieve anything worthwhile we have to make sacrifices and overcome barriers. No success comes easily.

A healthy body, a clear mind, energy for living, and freedom from so many of the scourges of modern life require persistence in small, sustainable changes. We should start slowly, but gradually stretch the limits of our capabilities. You may have pain walking or jogging, but you can strengthen your upper body and torso; you may be able to swim with freedom of pain, or cycle. Where theres a will, theres a way. You may need to counsel with a physiotherapist or a personal trainer, but there are ways you can improve your physical activity.

I hope that the answers you have read to some of the common excuses has given you opportunities to reassess your commitment to change, and think creatively about how you can begin to enjoy the benefits of positive health changes.

Next week we will discuss the SMART pneumonic for implementing changes whether they be with exercise, or dietary changes, or stopping smoking, or dealing with stress in your life.

Until then, contemplate about what you want out of life.

Dave Glass

Dr David Glass graduated from UCT in 1975. He spent the next 12 years working at a mission hospital in Lesotho, where much of his work involved health education and interventions to improve health, aside from the normal busy clinical work of an under-resourced mission hospital. He returned to UCT in 1990 to specialise in obstetrics/gynaecology and then moved to the South Coast where he had the privilege of, amongst other things, ushering 7000 babies into the world. He no longer delivers babies but is still very clinically active in gynaecology. An old passion, preventive health care, has now replaced the obstetrics side of his work. He is eager to share insights he has gathered over the years on how to prevent and reverse so many of the modern scourges of lifestyle obesity, diabetes, ischaemic heart disease, high blood pressure, arthritis, common cancers, etc. He is a family man, with a supportive wife, and two grown children, and four beautiful grandchildren. His hobbies include walking, cycling, vegetable gardening, bird-watching, travelling and writing. He is active in community health outreach and deeply involved in church activities. He enjoys teaching and sharing information.

HAVE YOUR SAY

Like the South Coast Heralds Facebook page, follow us on Twitter and Instagram

See the original post:
Turning the Tide - Lifestyle Medicine and change (part 7) - South Coast Herald

Read More...

Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 – Interfax-Ukraine

Sunday, October 25th, 2020

In the modern world of rapid technological development, you need to do a lot to be successful and stay in the top. It is especially important to know how to stay healthy and enjoy a fulfilling life, be productive and push yourself beyond limits.

Answers to the most topical questions about upgrading the body and mind will be given at the first Biohacking Conference Kyiv, dedicated to innovative ways of improving health and prolonging youth. Organized by Smile-Expo, the event will take place on November 11, 2020.

Leading experts from various industries will speak at the event: doctors, scientists, gerontologists, biohackers and many others. Among them:

- Oleksandr Kolyada geneticist, research associate at the lab of epigenetics at the Institute of Gerontology, founder of DIAGEN lab.

- Lyudmyla Goncharova dietarian, immunologist, two-time winner of The Battle of Nutritionists TV show on STB, founder of Goncharova Clinic.

- Oleksandr Skorokhod Candidate of Biological Sciences, research worker at the Department of signaling cell systems at the Institute of Molecular Biology and Genetics at the National Academy of Sciences of Ukraine.

- Hlib Khodorovskyi meditation expert, experienced mindfulness trainer.

Experts will delve into the main biohacking tools and explain the interrelation of dieting and longevity. Separately, speakers will discuss how genetic researches help to detect health risks, determine parameters of food digestion, and draw up a disease prevention program. In addition, the reports will focus on a safe approach to sports training, the benefits of mindfulness meditations and health management intended to improve productivity in all areas of life.

About safety measures at the conference

To protect guests, speakers, participants, and sponsors of the event against catching coronavirus, Biohacking Conference Kyiv will adhere to all the requirements of the Ukrainian government and the Ministry of Healthcare aimed to prevent the spread of COVID-19.

The following preventive measures will be taken at event, among others:

- Admission to the event is allowed only in a protective face mask or respirator.

- Temperature screening at the entrance.

- Availability of antiseptics in the premises, where the event will take place.

- The number of conference attendees is restricted according to the requirements of the Ministry of Healthcare.

- The distance between chairs for guests will be at least 1.5 meters.

Organizer and venue

The event is organized by the international Smile-Expo company, which specializes in industry events dedicated to innovations.

Biohacking Conference Kyiv will be held at Oasis conference hall on November 11.

More info and registration: kyiv.biohacking.events

Interfax-Ukraine - General News Partner of the event.

See the article here:
Biohacking Conference Kyiv about Efficient Health Optimization Techniques to Take Place on November 11 - Interfax-Ukraine

Read More...

Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players – The Think Curiouser

Sunday, October 25th, 2020

The research report entitled GlobalPrecision Medicine SoftwareMarket 2020 added by Syndicate Market Researchprovides professional information to evaluate the most recent Precision Medicine Software market measurements and industry situation. The report offers the research methodology and approaches followed to clear up the Precision Medicine Software industry conditions. This report studies the all-important aspects of the Precision Medicine Software market based on current market conditions and focuses on future possibilities of Precision Medicine Software market during 2020-2026.

This report research enormously examines each and every specific deciding factor of the Precision Medicine Software industry on the basis of present financial condition, Demand, Trends, Limit, Capacity, procedures encapsulated by Precision Medicine Software market competitor and their advancement framework.

Get FREE Sample Copy of Report:https://www.syndicatemarketresearch.com/sample/precision-medicine-software-market

(We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis)

The research highly targets on the current industry size of the Global Precision Medicine Software market and its improvement capacity on the basis of the last 5 years data with company profile of leading players and manufacturers. The major key regions which add to the progression of Precision Medicine Software market mostly cover such as Precision Medicine Software market in North America, South America, Europe, Africa, the Middle East, and the Asian countries.

Top Players and Manufacturers Analysis in Precision Medicine Software Market:Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42 Inc, Lifeomic Health

Do Inquiry for Purchasing Report Here:https://www.syndicatemarketresearch.com/inquiry/precision-medicine-software-market

This Precision Medicine Software Market report separated into the;1. Top manufacturers2. Product Type (Cloud-based, On-premises)3. Application/ end users (Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Other)4. Key Regions

Key regions covered in the world Precision Medicine Software market report include:

The five regions are in turned segment into major countries and geographies. The key countries included in the global Precision Medicine Software market report includeU.S., Canada, Germany, UK, Italy, France, Spain, China, India, Southeast Asia countries, South Korea, Japan, Australia, GCC countries, Turkey, Brazil, Egypt, Mexico, and South Africa among others.

(Our Analystcan add Regional analysis as per your Research need also)

In the first part, The Precision Medicine Software market report provides company profiling, product picture, contact information and requirements of key producers of the global market. This report comparatively delivers the past, present, and futurist Precision Medicine Software industry strategies, organization capacity, size, share, growth, and forecast analysis be featured the predicted circumstances. Moreover, the possible results and the hazard to the improvement of Precision Medicine Software market comprehensively described in this report.

In next part, the Precision Medicine Software report delivering investigation of the most essential industry players based on their organization profiles, sales volume, Precision Medicine Software market value, yearly income, gross margin, demand and supply is considered in this report, which can drive opportunity Precision Medicine Software market competitors in dynamic business parts of learning.

Browse Complete Report with [emailprotected]https://www.syndicatemarketresearch.com/market-analysis/precision-medicine-software-market.html

Key Highlights of the Precision Medicine Software Market:

Detailed research of the standard Precision Medicine Software market makers can ask the entire market to review the modernize plans and propelling examinations. Centered review of Precision Medicine Software market depends upon expansion, drive confining components and point of speculation can presume the market progress. The investigation of developing Precision Medicine Software market fragment and the dominating business sector will deal with the readers to plan the business strategies. The essential appraisal identified with Precision Medicine Software industry like the cost, sort of uses, the meaning of product, demand, and supply elements are acknowledged in this study report.

In the final part, the Global Precision Medicine Software Market report 2020 portrays business improvement designs, the Precision Medicine Software sales channel, wholesalers, buyers, merchants, studies findings, reference area, measurements sources and more.

Thanks for reading this Report; you can also get specific chapter wise, section wise or region wise reports.

Read another Report:-https://www.openpr.com/news/2160425/global-blockchain-technology-in-healthcare-covid-19

About Syndicate Market Research:

At Syndicate Market Research, we provide reports about a range of industries such as healthcare & pharma, automotive, IT, insurance, security, packaging, electronics & semiconductors, medical devices, food & beverage, software & services, manufacturing & construction, defense aerospace, agriculture, consumer goods & retailing, and so on. Every aspect of the market is covered in the report along with its regional data. Syndicate Market Research committed to the requirements of our clients, offering tailored solutions best suitable for strategy development and execution to get substantial results. Above this, we will be available for our clients 247.

Contact US:

Syndicate Market Research244 Fifth Avenue, Suite N202New York, 10001, United StatesEmail ID:[emailprotected]Website:https://www.syndicatemarketresearch.com/Blog:Syndicate Market Research Blo

Link:
Global Precision Medicine Software Market 2020 Recovering From Covid-19 Outbreak|Know More About Brand Players - The Think Curiouser

Read More...

What’s Behind All the Pro-Azerbaijan Articles? – Armenian Weekly

Sunday, October 25th, 2020

Azerbaijans President Ilham Aliyev has opened another battlefront thousands of miles away from Baku, in the pages of local and national newspapers and news sites in the US. Much like the Syrian mercenaries Baku recruited and deployed with the help of Turkish defense contractors to target Armenians, Azerbaijans US-based lobbyists are at the forefront of an information warfare that costs millions of dollars annually.

One important aspect of the work of these lobbyists is to place, disseminate and promote anti-Armenian narratives. Their tactics have evolved into a relentless smear campaign through US media outlets, painting Armenia as a close ally of Iran that undermines Western policies and Armenians as intolerant and anti-Semitic. At the same time, Azerbaijan is depicted as a beacon of tolerance, an ally of Israel and a champion of religious rights.

Bakus lobbyists continually push this narrative by placing articles in various media outlets, reaching out to editors with numerous factsheets and disseminating Baku-approved stories to contacts in positions of power. Many such propaganda pieces that are essentially commissioned by the Azerbaijani government appear in US media outlets without proper disclaimers, and therein loom the danger and deception.

Foreign Agents Registration Act (FARA) filings by Azerbaijans lobbyists show how they approach almost every major outlet from Bloomberg to CNN, the Washington Post, the Jerusalem Post, the New York Times, NBC, Al-Jazeera, San Francisco Chronicle, Sacramento Bee, Haaretz, USA Today, and Wall Street Journal; the list is almost interminably long.

Over the past few weeks, numerous articles have discussed Azerbaijans war on Armenia; many have had a bias, some suspiciously so. It may be impossible to tell which are penned by Aliyevs supporters and which are commissioned or disseminated by Bakus agents here; but a few are (and will be) known because of FARA filings.

From comments left under strikingly pro-Azerbaijani articles, it is clear that many readers have been frustrated and disheartened. Arguably, readers have a right to know whether the content they are consuming is either commissioned or part of a foreign governments information warfare. Without proper disclaimers under articles received from embassies by way of lobbyists, editors risk tarnishing the credibility of the news outlets they represent and deliver a blow to the idea of journalistic integrity. A simple one-liner would suffice, such as, This article was sent to us by [insert name of PR firm] on behalf of the Embassy of the Republic of Azerbaijan to the United States of America. Editors uncomfortable with such disclaimers might reconsider running blatant propaganda pieces that essentially import the state-sponsored narrative of a country with one of the worst media freedom records.

To give readers a clearer idea of how Azerbaijans lobbyists place and disseminate narratives that support Bakus propaganda campaign, I will take a close look at the activities of certain lobbyists employed by Aliyevs government, by examining hundreds of pages of FARA filings available in the US Department of Justice (DOJ) online archives.

An Information Warfare

In an Aug. 25 article titled Russia and Irans Dangerous Energy Gambit in the Caucasus and published by the Begin-Sadat Center for Strategic Studies, human rights lawyer and national security analyst Irina Tsukerman embraces all the talking points put out by Baku. She refers to Artsakh as a fake republic and an ersatz entity. After a series of hypotheticals (like Russia and Armenia might join forces to bring Russian biological weapons close to Azerbaijan), she proceeds to advise Baku on how to handle pro-Armenian sentiment in the west.

Azerbaijan should form a closer joint defense relationship with the US, benefiting from joint training and insights from experienced field operatives and officers. Additionally, greater resources need to be marshalled for information warfare and the political aspect of the battle being waged, including supporting professional media to counter disinformation, building personal and long-term relationships with public officials at all levels, and, most importantly, vigorously pursuing legislative and legal relief in US, European, and international bodies. Armenian officials responsible for human rights abuses should be sanctioned, she writes (italics my own).

Since a large chunk of her article deals with the Armenian National Committee of America (ANCA), which is active in DC, one might understand that Tsukerman is essentially encouraging a foreign government, Azerbaijan, to wage information warfare against a grassroots Armenian-American organization that promotes and advocates for the interests of and issues important to American citizens of Armenian origin. In other words, she is calling on Azerbaijan with its dismal media freedom record to export its relentless propaganda to the US.

In its 2020 report, Freedom House designated Azerbaijan as a consolidated authoritarian regime with a score of 10/100, observing that Constitutional guarantees for press freedom are routinely and systematically violated, as the government works to maintain a tight grip on the information landscape. Defamation remains a criminal offense. Journalists and their relatives face harassment, violence and intimidation by authorities. Many have been detained or imprisoned on fabricated charges, while others face travel bans. Armenia fared as partly free, with a score of 53/100. The report noted Independent and investigative outlets operate relatively freely in Armenia, but their work is generally found online.

We may not know what motivates Tsukermans anti-Armenian rhetoric; she has no known ties to current lobbyists for Baku.

On Oct. 20, another one of Tsukermans articles, co-authored by Jason Epstein, was published by Newsweek. Tsukerman and Epstein unite in [their] support of Sunni-majority Turkeys Shia ally, Azerbaijan, an unabashedly pro-Western country, as it is unfairly smeared. The article argues that the war is not about religion; it discusses Azerbaijans secularism, the Popes 2016 visit to Baku, religious minorities in Azerbaijan, and Ashkenazi, Georgian and Mountain Jews.

No wonder Iran, the largest Shia country in the world but with ethnic Azeris comprising of up to 30 percent of its population, feels threatened by a tolerant Azerbaijans continued geopolitical success and therefore supports Armenia, write the authors. Tsukermans co-author Epstein is the president of Southfive Strategies, LLC and a former public relations consultant for the Turkish Embassy in Washington (2002 2007); he has long considered [himself] both pro-Israel and pro-Turkey. Among Southfives past clients are the Azerbaijan Diplomatic Academy in Baku, the Turkish Embassy in Washington and the Turkish Republic of Northern Cyprus Washington office.

Epsteins work with the Azerbaijan Diplomatic Academy, which is funded by the Azerbaijani government, began on Aug. 1, 2008, when Epstein registered as a foreign agent with the DOJs FARA unit for his work with the Academy. In describing his engagement with that entity, Epstein wrote, Assisting the Academy in producing a policy conference in Azerbaijan on US-Azeri relations, as well as meetings with Azeri officials, business leaders, religious leaders, and media personalities.

When asked whether Southfive would engage in political activities and what those activities might entail, Epstein responded, Encouraging journalists to file stories on US-Azeri relations, based on their experiences at the conference and during various meetings.

The disclaimer under the Newsweek article reads: Jason Epstein is president of Southfive Strategies, LLC, an international public affairs consultancy. Irina Tsukerman is a New York-based human rights lawyer and national security/geopolitical analyst, the vice president of Timberwolf Phoenix, a media and security consultancy, and an adviser to the London-based International Justice Organization. The views expressed in this article are the writers own.

There is no mention of Epsteins past lobbying work for the governments of Azerbaijan and Turkey. A reader would have to independently research Southfive Strategies to learn that for years it had engaged in lobbying on behalf of Azerbaijan and Turkey.

Bakus US Agents

A FARA filing by the Podesta Group in 2013 details the extent of its outreach to US politicians, universities, think tanks, but also most major news outlets, including Bloomberg, Foreign Policy, CNN, Washington Post (and Times), EurasiaNet, Associated Press, USA Today, Wall Street Journal, Jerusalem Post, Al-Jazeera, Los Angeles Times, NBC, New York Times and Haaretz.

Just between June and December of 2017, Podesta received $260,735.56 for its work on behalf of the Azerbaijani Embassy in the U.S., according to a Department of Justice (DOJ) report. That year, Podesta was one of four companies registered with the DOJ for work on behalf of Azerbaijan that cost Baku $560,735.56. During a six-month period that same year, 16 companies worked on behalf of Turkey with a total (reported) price tag of $4,284,020.06. Meanwhile, during the six-month period, an Avedis Boyamian offered pro-bono policy consultation to Armenia; price tag: $0. This information is available in the DOJ report titled, Report of the Attorney General to the Congress of the United States on the Administration of the Foreign Agents Registration Act of 1938, as amended, for the six months ending December 31, 2017.

Among the lobby groups that have represented Azerbaijan in the past couple of years are the Livingston Group (contract terminated on Oct. 13), Stellar Jay Communications, BGR Government Affairs, Sanitas International, Rasky Partners (click here for an earlier and more detailed contract, and here and here for samples of their media outreach), and Baker Donelson (contracted by BGR). Meanwhile, another lobbying firm, S-3 Group, which works on behalf of the Baku-based Investment Corporation owned by Seyidov Tural Oglu, has create[d] and place[d] earned and digital media to further diplomacy between America and Azerbaijan, according to a DOJ filing; for instance, S-3 sent out pro-Azerbaijan factsheets on Oct. 15.

To get an idea of the ties, experience and expertise some of these lobby groups retain, a quick glance at the rank and file of BGR Public Affairs will suffice. Among their team members are: former Governor of Mississippi Haley Barbour; former Policy Director at the Senate Finance Committee Matt Hoffmann; Former Representative Sean Duffy (R-WI); former Senior Executive Clandestine Service Officer with the Central Intelligence Agency (CIA) Daniel Hoffman; former FBI man Tom Locke; former US Ambassador to NATO Kurt Volker; former Director of Legislative Affairs for the National Security Council Mark Tavlarides; former senior USAID official Lester Munson; a Frank Ahrens who can arrange client interviews with Fox News, CNN, The Washington Post and major wire services; and a Jeff Birnbaum who is a former White House, congressional and tax reporter for the Wall Street Journal, a senior political correspondent for Time Magazine, Washington bureau chief for Fortune Magazine and a columnist for the Washington Post.

When Azerbaijan and Turkey pay millions to employ such lobbying firms, they are in effect buying ease of access to major national news services.

A Stellar Case

The case of one public relations firm employed by Baku might offer a glimpse into the Azeri lobbying efforts through pro-Azerbaijan articles in US media. The articles pushed on various editors deal with that general theme of tolerant Azerbaijan and intolerant Armenia. Whatever information warfare Tsukerman might have been alluding to in her article is displayed below.

At the center of the story is Jacob Kamaras, the former editor-in-chief of the Jewish National Syndicate (JNS), where pro-Azerbaijan and anti-Armenian articles have appeared in the past two years (for instance, Irina Tsukermans Oct. 12 article), including pieces that promote denial of the Armenian Genocide. Kamaras is the founder and chief of Stellar Jay Communications, which actively lobbied for the Azerbaijani Embassy in the US in 2020, and about which Julian Pecquet, founder and editor of the Foreign Lobby Report, has written. Note that Kamaras has filed a Fictitious Business Name Statement for his company with the DOJ.

Kamaras registered to lobby for the Azerbaijani Embassy on Jan. 31, 2020. The DOJ form informs that the registrant engages with Azerbaijans Ambassador Elin Suleymanov and receives a $3,300 fee per project. Kamaras principal mode of operation is through outreach to newspapers and editors, as noted in another DOJ file. Still another DOJ filing reveals that Kamaras, whose work for the Embassy entailed media consulting and op-ed placement, was paid $56,100 between Feb. 17 and July 10, 2020, presumably for 17 projects.

Among the papers Kamaras submitted to the DOJ are a number of emails he sent to news outlets, urging them to publish certain pro-Azerbaijan articles and offering certain pro-Azerbaijan talking points. There are 14 files (excluding the companys registration) that span the first eight months of the year; the last disclosure is dated August 7.

Propaganda: Israel Should Ally with Tolerant Azerbaijan

In the first email dated Feb. 12, addressed to the editors at the conservative CNSNews.com, Kamaras asks the news website to consider publishing an article by Maayan Hoffman, the news editor at The Jerusalem Post, titled, A Jewish-Muslim paradigm for peace. Hoffman argues that Azerbaijan has pioneered a paradigm for warm Muslim ties with Israel, the nation Tehran repeatedly vows to wipe off the map Israel only stands to benefit from having an ally like Azerbaijan on the border of arguably the Jewish states fiercest enemy. She stresses that Jews live in Azerbaijan in peace and prosperity and details various developments in the benevolent attitude of Baku towards its Jewish minority population.

Kamaras email (like all his other emails discussed below) ends with a disclaimer noting that the email and its contents are sent by Stellar Jay Communications on behalf of the Azerbaijani Embassy.

On Feb. 13, CNSNews published the story, slightly altering the headline to read, Heres What a Jewish-Muslim Paradigm for Peace Looks Like. A brief bio of the author appeared below the article: Maayan Hoffman is news editor and head of online content and strategy at The Jerusalem Post. She has been an American-Israeli international journalist for more than two decades. There was no mention of Stellar Jay Communications or the Azerbaijani Embassy.

Propaganda: Armenia is Anti-Semitic

Kamaras second email dated March 9 is addressed to Rob Shimshock of CNSNews, containing yet another article, this time by Jesse Bogner and titled The old anti-Semitism is alive and well. This piece alleges that there is medieval-style anti-Semitism coming from Armenian organizations and commentators, and that [T]he ANCAs recent rhetoric on Twitter represents the latest indicator of not only the anti-Semitism emanating from Armenia, one of the worlds oldest Christian nations, but also of the disturbing perpetuation of classical Christian anti-Semitism. Of course, Bogner portrays Azerbaijan as a haven of tolerance. By contrast, Armenias Muslim-majority neighbor has a deep relationship with Israel, no history of anti-Semitism, and a prosperous Jewish community of its own for more than two millennia, he writes.

Apparently CNSNews did not publish Bogners article. On March 15, the piece was published on Bogners blog on The Times of Israel. Again, there was no mention of the Azerbaijani Embassy; just Bogners bio: Jesse Bogner is an author and journalist. His memoir and social critique, The Egotist, has been translated into five languages. His work has been featured in The Daily Caller, MSN, The Daily Wire and The Huffington Post. His book of articles, Tikkunim (Corrections), was released in January 2018.

It is outside the scope of this article to counter such propaganda. However, I will refer you to Yoav Loeffs Jan. 27 article titled, Armenias Antisemitism? The Truth Is Different, in The Jerusalem Post, which he wrote coincidentally in response to a piece by Hoffmanthe same Hoffman whose articles Kamaras disseminated on behalf of Azerbaijans Embassy. Loeff, who teaches Armenian history and culture at the Hebrew University of Jerusalem, is Jewish and has traveled to Armenia with other Jews and Israelis on many occasions, and stresses that he has never heard a hint of antisemitic expression.

If there is some criticism, it is usually about Israels hesitation to recognize the Armenian genocide that was perpetrated by the Ottoman Empire he writes.

Armenias small Jewish community never suffered antisemitism in their adopted homeland. Most of them left in the early 1990s, after the severe earthquake in the north of the country in 1988 and the collapse of the Soviet Union, explains Loeff. He notes the dire economic situation following the earthquake and the Artsakh war and adds, They did not leave because they faced any antisemitism; they left because they sought better life.

Loeff also discusses the various ways in which Armenian government representatives had honored Holocaust victims, from Armenian President Armen Sarkissians attendance at the World Holocaust Forum in Jerusalem to the erection of a monument in Yerevan in memory of the victims of the Holocaust and the Armenian Genocide. Unfortunately, there is no parallel such monument in Israel, he adds.

Propaganda: Azerbaijan is a Friend to Israel

On March 13, Kamaras emailed The Jewish Voice editor Fern Sidman, offering him a piece by Hoffman, this time titled, Could fighting coronavirus be the latest frontier in the Israel-Azerbaijan relationship? Hoffman noted the presence of Azerbaijans Finance Minister Samir Shafirov at the AIPAC Policy Conference and quoted him to have said, Cooperation with Israel is not limited to oil supply; we are interested in widening cooperation in defense and the transfer of technology. Apparently Shafirov also read Azerbaijans first-lady-turned-vice-president Mehriban Aliyevas remarks praising Azerbaijani-Jewish ties in the US. The gist of the article was the importance of strengthening Azerbaijani-Israeli ties. The email closed with the usual disclaimer about Kamaras communicating on behalf of the Azerbaijani Embassy.

Hoffmans piece was accepted and published without any mention of Kamaras firm or the Azerbaijani Embassy. However, some days later, NBC news published a piece highlighting Hoffmans article as an example of foreign governments using American lobbyists to promote their efforts to fight the coronavirus outbreak and safeguard their countries reputations in the U.S. capital. NBC goes on to point out that The piece was written by Maayan Hoffman, identified as a Jerusalem Post news editor, but the published version makes no mention that the commentary was placed by Stellar Jay Communications, a lobbying firm representing the government of Azerbaijan, as a FARA filing shows.

NBC was right about foreign governments promoting their countries, safeguarding their reputations and placing op-eds in various papers. What NBC failed to understand is that this was not about the coronavirus, but part of an information war that ultimately feeds and bolsters the myth of the religiously tolerant Azerbaijan and the intolerant Armenia; and that is one of the key objectives of Baku, and by extension their US agents.

Propaganda: Armenia is a Friend to Iran

On April 23, Kamaras sent out another email to CNSNews with an article written by Bogner, whoin Kamaras wordsexamines how the coronavirus is not stopping Iran from fueling conflict and undermining sanctions through its proxies. Specifically, he looks at Armenias role in empowering Iran economically. The article, titled, Coronavirus doesnt stop Iran from fueling the fire of conflict, accuses Iranian trucks of delivering fuel to Nagorno-Karabakh, the Armenian-occupied region which several U.N. resolutions affirm as part of Azerbaijan, charges Armenian banks of enabling Tehran, and faults Democratic US lawmakers for having a pro-Armenian policy agenda.

The article ignores Azerbaijans ties with Iran, the fact that in 2019 Azerbaijans imports from Iran were worth US $452.63 million and exports at US $41.13 million, while Armenias imports from Iran were worth US $324.7 million and exports at US $83.84 million, according to the United Nations COMTRADE database. In other words, both countries maintain an economic relationship with their sanctioned neighbor.

Once again, Bogners piece did not appear in CNSNews and instead was published on his blog on the Times of Israel without any mention of the Azerbaijani Embassy or Jay Stellar Communications.

Propaganda: Azerbaijan Champions Religious Freedom

Kamaras next email (May 6) was also to CNSNews, in which it becomes clear that Rob Shimshock (the recipient) did not respond to the lobbyists previous two emails (which also explains why Bogners pieces ended up on his blog). This time, Kamaras submits his own article titled Azerbaijans postponed Formula 1 race transcends sports about which he tells Shimshock, I write that despite the events postponement this year, the annual Formula 1 auto race hosted by Muslim-majority Azerbaijan particularly during the Islamic holy month of Ramadan is a powerful display of religious freedom, especially in a world plagued by sectarian conflict and now by the invisible enemy of the coronavirus.

What Kamaras fails to mention is that Freedom House gave Azerbaijan a score of 0 out 4 for religious freedom in its 2020 report, which noted, The regime exercises control over religion through state-affiliated entities such as the Caucasus Muslim Board. Religious communities that attempt to operate independently face burdensome registration requirements, interference with the importation and distribution of printed religious materials, and arrest and harassment of religious leaders with international ties or a significant following. In other words, the idea of a religiously tolerant Azerbaijan is a myth nurtured by Bakus agents abroad.

In any case, at the end of the article submission, Kamaras includes his bio: Jacob Kamaras, former editor in chief of the Jewish News Syndicate, is noted for his work on the Middle East and American politics. His writing has appeared in the Washington Times, Independent Journal Review, the American Spectator, and various Jewish and Israeli media. It makes no mention of his role as a lobbyist on behalf of the Embassy of Azerbaijan to the US. However, the email does end with the usual disclaimer.

CNSNews published the article on May 7, slightly altering the title to read, Azerbaijans Grand Prix Transcends Sports, Speaks to Religious Freedom. However, it added the following to Kamaras bio: Jacob Kamaras is founder of Stellar Jay Communications, a PR firm representing Azerbaijan. The next day, another lobbyist on behalf of Azerbaijan, Mark Tavlarides of the BGR Group, emailed the article out to relevant contacts, urging them to read it.

Propaganda: Israel and Azerbaijan are Partners (and Trailblazers in the Understanding of Aging)

A few days later, Kamaras reached out to the editor of the Salinas Californian, Silas Lyons, with a story written by Diana Cohen Altman, former executive director of the Karabakh Foundation and a contributor to the JNS. Altmans piece was about Azerbaijanis who live up to 120 years old in Lankaran. Altman discusses diet, genetics and clusters of very old people in Azerbaijan, as well as longevity in Ashkenazi Jewish populations. Quoted in the piece is a surgeon who is a member of the Azerbaijan-Israel Inter-Parliamentary Work Group. The piece concludes with yet another nod to Azerbaijani-Israeli friendship with these words: Azerbaijan has fostered significant partnerships in the humanities and other disciplines, and the West is building an understanding of Azerbaijani culture and contributions. Amid the pandemic and in the coming years, the U.S. scientific community may look to Israel and Azerbaijan who are partners in technical and other arenas for breakthroughs in the understanding of aging.

The piece did not appear in The Californian. Instead, it was published by The Jerusalem Post on June 4. The final paragraphs were altered a bit, and there was this addition: The Azerbaijani superaging phenomenon may also be of particular interest to social scientists, given major societal changes during the past century. Consider this: Someone over the age of 100 might have witnessed what is now the Republic of Azerbaijan as a portion of the Russian Empire, a part of the early Azerbaijani Democratic Republic, and as an S.S.R. of the Soviet Union. In effect, this addition attempts to insert a historical footnote in this article that on the surface appears to be about longevity.

Altmans bio appears at the end of the piece: Diana Cohen Altman, principal of Cultural Diplomacy Associates, L.L.C., and former executive director of the US cultural non-profit Karabakh Foundation, writes extensively about Azerbaijani cultural and civil-society topics. It made no mention of the Embassy of Azerbaijan or Jay Stellar Communications. Also to note, Altman is still listed on the Karabakh Foundations website as its Executive Director.

Propaganda: Armenians are Intolerant, Anti-Semitic

On June 11, through Kamaras, Baku resorted again to charges of anti-Semitism as a desperate attempt to vilify Armenian Americans. An email informs that Kamaras own article appeared in BreakingIsraelNews (Israel365News.com), titled Armenias Self-Defeating Campaign Against Christians. The article ran as an op-ed. It decried Armenian-American opposition to evangelical pastor Rev. Johnnie Moores support of Azerbaijan and Trumps Middle East policies, singled out Asbarez news for its coverage and bashed the ANCA, accusing it of anti-Semitic tweets.

Although at the base of his email, Kamaras included his disclaimerThis material is distributed by Stellar Jay Communications on behalf of the Embassy of the Republic of Azerbaijan to the United States of Americathe published article made no mention of the authors bio or of his work on behalf of the Azerbaijani Embassy. Readers were (and continue to be) misled into believing the piece was written by a concerned writer and not a paid agent of Azerbaijans propaganda campaign. The Azerbaijani news.az reprinted the article, also without any mention of Kamaras role as a foreign agent for Baku.

Propaganda: Armenia is an Occupier; Unreliable Partner; Aids Iran

On July 14, Kamaras approached The Washington Free Beacon with a list of Azerbaijani talking points on the escalation of violence between Armenia and Azerbaijan. I wanted to share a few angles below that could help you provide broader context in any story, if you choose to pursue one. Should you want to set up a phone interview with the ambassador, please let me know and Ill be happy to arrange it, wrote Kamaras. The Beacon did not take him up on the offer. In fact their last report that even mentions Azerbaijan ran in January of this year. Nonetheless, its worth reviewing Kamaras talking points.

Aside from highlighting some European support for Azerbaijans territorial integrity, Kamaras shared an article by none other than Bogner in American Thinker titled, Democrats West Bank rhetoric rings hollow, in which the author asks, Where is the condemnation of Armenias occupation of the same percentage of internationally recognized Azerbaijani territory, in the Nagorno-Karabakh region?; another article by Paul Miller in the JNS titled, Beware of the sanctions busters, accuses Armenia of offering the [Iranian] mullahs one of their best escape routes from crippling American sanctions; as well as Hoffmans article in BreakingIsraelNews titled, A Nation that is Faithful to Iran Is no Reliable Partner (one can glean the spirit of the article from the title). He also shared a July 7 article in Arab News by Iranian American journalist Adelle Nazarian, a foreign policy analyst with Breitbart News who was in Azerbaijan in 2019. In it, Nazarian argues that Now is the time for US lawmakers to echo Europes support for territorial integrity. Hypocrisy should no longer be accepted.

Propaganda: Armenians are Plagued by Extremist Ideologies(Like Nazism and Anti-Semitism)

On July 13, Kamaras emailed Fox News correspondent Hollie McKay, offering her the opportunity to interview Azerbaijans Ambassador to the US Elin Suleymanov. McKay had interviewed the Ambassador in March 2019. She did not interview the Ambassador in July, but Fox News did speak with him on Sept. 28, just as Azerbaijan launched its offensive. (On Oct. 4 McKay did report on the recruitment of Syrian fighters by Turkish defense contractors to fight in Azerbaijan).

In early August, Kamaras approached a number of news sites on behalf of Amb. Suleymanov. On Aug. 5, he emailed Mercury News asking them to publish an article penned by the Ambassador, titled Hate crimes have no place under the California sun.

The Ambassadors article centers on a scuffle between Armenian and Azerbaijani protesters in Los Angeles. He proceeds to highlight some statements from Jewish American groups regarding the incident and suddenly hurls allegations of anti-Semitism. Both Armenia and the Armenian communities abroad have long been plagued by extremist ideologies, political violence and a complicated history with anti-Semitism, Nazi collaborators and Middle Eastern radicals, he writes.

Such broad charges are not only insulting to Armenians worldwide and Armenian Americans, many of whom fought the Nazis, but also warps history, erasing the sacrifices of many like the members of the Manouchian Group, one of the most active French resistance groups. Of course, this is coming from the representative of a government that wholeheartedly joins neighbor Turkey in its unashamed and continued denial of the genocide perpetrated by its Ottoman Turkish predecessor.

Essentially, the Ambassador is relying on charges of anti-Semitism against Armenians to draw support for the Azerbaijani policies and claims against Artsakh. By doing so, he is using the very real presence and danger of anti-Semitism in the world as a tool to further Bakus agenda and in the hopes of garnering Jewish American and Israeli sympathies. As Kamaras previous emails show, Bakus tactics have at their core the manipulation of fears towards both Iran and anti-Semitism.

The Ambassadors article was presumably rejected by Mercury News, because on Aug. 6 Kamaras submitted the same piece to the San Francisco Chronicle. Three minutes later, he sent the piece to The Sacramento Bee; and a minute later to The Hill. The article was finally published in The Monterey County Herald on Aug. 12, despite its overt propagandizing and vilification of Armenians worldwide.

That is the last of Kamaras activities submitted to the DOJ.

A Glance at BGR

Other lobby groups, such as BGR, also heavily publicized pro-Azerbaijan viewpoints and articles, and reached out to various media outlets for interviews, or to offer talking points. For instance, the DOJ FARA registration unit received a copy of an email from Mark Tavlarides of the BGR Group, which shared an article by the same Nazarian, titled, Azerbaijan: A Nation that Bears the Torch, and Burden, of Bringing Religious Freedom to its Less Tolerant Neighbours in the Region.

The author, Adelle Nazarian, visited Azerbaijans 5th World Forum on Intercultural Dialogue in Baku. Nazarian noted the insightful meetings and visits which left her acutely aware of the sensitive nature of Azerbaijans position as a potential kingmaker for the cause of religious freedom and unity between the three Abrahamic faiths in the region. She expressed hope that religious freedom would also flourish in Azerbaijans neighbors in the region, wrote Tavlarides in his email.

Tavlarides has on many occasions disseminated pro-Azerbaijan articles on behalf of the Embassy, such as a piece by Hoffman in the JNS, titled Azerbaijani national hero provides a paradigm for Jewish-Muslim relations. On numerous other instances, Tavlarides sent out the links to articles, official Azerbaijani statements, resources, factsheets (including an Oct. 5 email), press releases, the pro-Azerbaijan statements of various organizations and politicians, and tweets such as one sent out by Israels Ambassador to the US touting Azerbaijan as a beacon of religious tolerance, as well as another one by Luke Coffey, director of Foreign Policy Studies at The Heritage Foundation, critical of Armenia and Armenians.

In a turn from the cynical to the absurd, Tavlarides also disseminated a link to an episode of the CBS show Seal Team, which depicts the fictional support of elite US forces to help protect an Azerbaijani power plant from a potential attack by Armenian loyalists, Shiite militia, or foreign powers looking to reduce American influence in the region. Tavlarides went on to stress that The scene emphasizes the strategic role of Azerbaijan as our only ally in the Caspian Sea and a deterrent to unaligned powers in the area.

Azerbaijan paid BGR $510,000 in 2019, $600,000 in 2018, and $490,000 in 2017.

The Case of Brenda Shaffer

In 2015, Till Bruckner of the Organized Crime and Corruption Reporting Project (OCCRP) published a piece titled, How to Build Yourself a Stealth Lobbyist, Azerbaijani Style. The focus of the article is Brenda Shaffer, a visiting researcher and adjunct professor at Georgetown University, a Senior Fellow at the Atlantic Councils Global Energy Center, professor at the University of Haifa, and former head of the Caspian Studies Program at Harvard, which was funded by the Azerbaijan Chamber of Commerce. Bruckner discusses Shaffers various activities and lays out her myriad connections with Azerbaijans lobbyists, including her role as adviser to the State Oil Company of the Azerbaijan Republic (SOCAR).

According to Bruckner, Shaffers activities included testifying before the House of Representatives Committee on International Relations, contributing to various DC think tanks (including a panel discussion on Azerbaijan, hosted by the Carnegie Endowment for International Peace, during which she reportedly praised the countrys vibrant press), and writing numerous op-eds for US and Israeli news outlets. She was often consulted on matters relating to Azerbaijanwhether by the media or US officials.

Supported by an overseas regime and an assorted network of overt and undercover lobbyists, she used oil money to build her academic credentials, then in turn used those credentials to promote Azerbaijans agendas through Congressional testimony, dozens of newspaper op-eds and media appearances, countless think tank events, and even scholarly publications, wrote Bruckner.

In a 2006 Harpers Magazine piece titled Academics for Hire, journalist Ken Silverstein wrote, Caspian watchers beware: the next time you see or hear an independent American expert talking about how the regions rulers are implementing bold reforms, check the experts credentials to see just how independent he or she truly is.

After inquiries by Bruckner, some newspapers like The New York Times and The Washington Post added disclaimers under Shaffers articles, disclosing her roles and ties to SOCAR. Others did not.

Shaffer continues to publish op-eds on the subject. For instance, on Oct. 14, JNS ran a piece by Sean Savage titled, How the Armenian-Azerbaijani conflict could impact Israels regional strategic landscape.

Israel and Azerbaijan maintain a strategic alliance. It is not just about arms sales or oil, but a very deep strategic cooperation, she told JNS, adding, Israel has friendly ties with the Armenian people and is home to a vibrant Armenian community. On strategic issues, however, the two states are on different sides. Armenia has close cooperation with Iran, and much of the military supplies to Armenia today transit Iranian territory.

Shaffers credentials were left as a senior fellow at the Atlantic Councils Global Energy Center. The JNS piece was reprinted in multiple outlets.

Armenian Americans Fight Back

The ANCA, the Armenian Assembly and many concerned Armenian Americans have been vocal with their efforts to pressure lobbyists to back down and terminate their contracts, as Foreign Lobbys Pecquet reports. Already over the weekend, the Armenian diaspora bombarded the S-3 Group with more than a thousand emails with an identical message pressuring the Washington public affairs firm to stop representing a new client from Azerbaijan (Foreign Lobby Report was copied on the emails), wrote Pecquet, adding, The firm recently picked up a Baku-based company called Investment Corporation, LLC for $25,000 per month to create and place earned and digital media to further diplomacy. The diaspora letter, which you can read in its entirety here, describes S-3s client as a thinly veiled front for the Government of Azerbaijan through a proxy shell corporation.

Their aim is to vilify Armenians worldwide.

The Livingston Group terminated its contract with the government of Azerbaijan on Oct. 13. Pecquet notes that this came three months after the lobby group informed the DOJ that it was negotiating another contract with Baku. Pecquet also reported that DLA Piper, a lobby group working for the state-owned Azerbaijan Railways CJSC, terminated its contract on Oct. 19. DLA Piper was contracted to provide the foreign principal with legal advice and assistance relating to U.S. sanctions on Iran that affect the transport of oil, gas, and other petrochemical products that originate in third countries and that transit through Iran.

Meanwhile, the lobbying firm Mercury Public Affairs cut its ties with Turkey on Oct. 23, after pressure from the Armenian American community. The decision came following protests led by the ANCA and the Armenian Assembly outside the firms offices, as well as pressure from current clients like Los Angeles County, California State Assembly, and Los Angeles Community College District representatives, reported Politico.

A lot of people have bought a lot of summer homes and fishing boats and put their grandkids through college by lying about Armenia and covering up for Azerbaijan, ANCA Executive Director Aram Hamparian told Politico.

Hamparian said that BGR was next on the list.

Fact: Baku Aims to Vilify Armenians through US Media

Some of the articles disseminated by these lobby groups employed by Azerbaijan cross-link with others written by authors like Bogner, desperately trying to paint Armenia as a threat like Iran, and Armenians as anti-Semites. Reading these articles, one might not even realize that there is a Jewish community in Armenia as well, and they too have spoken up (See Lara Setrakians article in Haaretz titled, Im Jewish and Armenian. Israeli Weapons Are Killing My People). Their existence is not weaponized in western media by either Armenians or the Armenian government.

In all this, it is clear that Azerbaijans smear campaign against Armenia relies on those two tales: Armenia is dangerous; and Armenians are intolerant and anti-Semitic. The basic calculations run something like this: Israel is good; Iran is bad; Armenia is to Azerbaijan what Iran is to Israel; therefore, Armenia must be bad, and Azerbaijan must be good; and furthermore, Israel and Azerbaijan must stand united, while Iran and Armenia are the enemy and must be sanctioned. These are the points that are being pushed by Bakus lobbyists to elicit an unfavorable public perception of Armenia and Armenians. Their aim is to vilify Armenians worldwide. The sheer number of articles pushing this narrative is astounding. Some of them are paid for and disseminated by Azerbaijans lobbyists, and published without any disclaimers to highlight that fact. The propaganda is so blatant that one wonders how anyonewhether readers or editorscould take any of these pieces seriously.

However, the responsibility to vet and flag such articles falls squarely at the feet of editors. By publishing articles without the appropriate scrutiny and disclaimers, editors are complicit in the disinformation campaign and agents of Bakus information war. Mercenaries and lobbyists are motivated by Aliyevs petro-dollars. One can only hope that editors are driven by the pursuit of truth; and those who are not should consider sending their resumes to the Azerbaijani Embassy in DC.

Authors note: Id like to thank Khatchig Mouradian for his feedback. This article does not deal with the activities of lobby groups working on behalf of Turkey, or the financial contributions of Azerbaijans lobby groups to US politicians running for office, or other activities and outreach efforts (such as the Oct. 2 Zoom session with Amb. Suleymanov and congressional staff hosted by BGR), as they are outside the scope of this piece. Those interested can read more about Azerbaijans lobbying efforts at Opensecrets.org, a website that tracks developments in the shady lobbying world.

Nanore Barsoumian was the editor of the Armenian Weekly from 2014 to 2016. She served as assistant editor of the Armenian Weekly from 2010 to 2014. Her writings focus on human rights, politics, poverty, and environmental and gender issues. She has reported from Armenia, Nagorno-Karabagh, Javakhk and Turkey. She earned her B.A. degree in Political Science and English and her M.A. in Conflict Resolution from the University of Massachusetts (Boston).

Continued here:
What's Behind All the Pro-Azerbaijan Articles? - Armenian Weekly

Read More...

Page 5«..4567..10..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick